Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Tuberculosis

  Free Subscription


Articles published in Int J Tuberc Lung Dis

Retrieve available abstracts of 716 articles:
HTML format



Single Articles


    May 2020
  1. PANG Y, Liu Y, Du J, Gao J, et al
    Impact of COVID-19 on tuberculosis control in China.
    Int J Tuberc Lung Dis. 2020;24:545-547.
    PubMed    


  2. DARA M, Sotgiu G, Reichler MR, Chiang CY, et al
    New diseases and old threats: lessons from tuberculosis for the COVID-19 response.
    Int J Tuberc Lung Dis. 2020;24:544-545.
    PubMed    


  3. PONTALI E, Tiberi S
    Green Light Committee and drug-resistant-tuberculosis: how to address the new challenges?
    Int J Tuberc Lung Dis. 2020;24:539.
    PubMed    


  4. HENG M, Allmendinger S, Chiang CY, Trebucq A, et al
    Progress in the roll-out of multidrug-resistant tuberculosis (MDR-TB) treatments.
    Int J Tuberc Lung Dis. 2020;24:535-536.
    PubMed    


  5. MONDONI M, Sotgiu G
    Endobronchial ultrasound-guided transbronchial needle aspiration and tuberculosis mediastinal lymphadenopathy.
    Int J Tuberc Lung Dis. 2020;24:534.
    PubMed    


  6. ARINAMINPATHY N, Chin DP, Sachdeva KS, Rao R, et al
    Modelling the potential impact of adherence technologies on tuberculosis in India.
    Int J Tuberc Lung Dis. 2020;24:526-533.
    PubMed     Abstract available


  7. GARFEIN RS, Liu L, Cuevas-Mota J, Collins K, et al
    Evaluation of recorded video-observed therapy for anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2020;24:520-525.
    PubMed     Abstract available


  8. KAWATSU L, Uchimura K, Ohkado A
    A cost-effectiveness study of tuberculosis and latent tuberculosis infection screening in prisons in Japan.
    Int J Tuberc Lung Dis. 2020;24:506-511.
    PubMed     Abstract available


  9. MAUG AKJ, Hossain MA, Gumusboga M, Decroo T, et al
    First-line tuberculosis treatment with double-dose rifampicin is well tolerated.
    Int J Tuberc Lung Dis. 2020;24:499-505.
    PubMed     Abstract available


  10. PARK SC, Kang MJ, Han CH, Lee SM, et al
    Long-term mortality of patients with tuberculosis in Korea.
    Int J Tuberc Lung Dis. 2020;24:492-498.
    PubMed     Abstract available


  11. BUTOV D, Lange C, Heyckendorf J, Kalmykova I, et al
    Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine.
    Int J Tuberc Lung Dis. 2020;24:485-491.
    PubMed     Abstract available


  12. ANDREWS JR, Cobelens F, Horsburgh CR, Hatherill M, et al
    Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town.
    Int J Tuberc Lung Dis. 2020;24:477-484.
    PubMed     Abstract available


  13. DENHOLM J
    Seasonality, climate change and tuberculosis: new data and old lessons.
    Int J Tuberc Lung Dis. 2020;24:469.
    PubMed    


  14. COX V, Wilkinson L, Grimsrud A, Hughes J, et al
    Critical changes to services for TB patients during the COVID-19 pandemic.
    Int J Tuberc Lung Dis. 2020;24:542-544.
    PubMed    


    April 2020
  15. KAPUR A
    Randomised clinical trials for tuberculosis prophylaxis in people with diabetes mellitus.
    Int J Tuberc Lung Dis. 2020;24:465-466.
    PubMed    


  16. SHEDRAWY J, Jansson L, Bruchfeld J, Lonnroth K, et al
    Health-related quality of life among persons treated for tuberculosis in a European setting.
    Int J Tuberc Lung Dis. 2020;24:461-463.
    PubMed    


  17. SCHWOEBEL V, Koura KG, Adjobimey M, Gnanou S, et al
    Tuberculosis contact investigation and short-course preventive therapy among young children in Africa.
    Int J Tuberc Lung Dis. 2020;24:452-460.
    PubMed     Abstract available


  18. YOUNG C, Barker S, Ehrlich R, Kistnasamy B, et al
    Computer-aided detection for tuberculosis and silicosis in chest radiographs of gold miners of South Africa.
    Int J Tuberc Lung Dis. 2020;24:444-451.
    PubMed     Abstract available


  19. MIKIASHVILI L, Kipiani M, Schechter MC, Avaliani Z, et al
    Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study.
    Int J Tuberc Lung Dis. 2020;24:436-443.
    PubMed     Abstract available


  20. PIERRE-AUDIGIER C, Talla C, Alame-Emane AK, Audigier B, et al
    Tuberculosis trends in a hot-spot region in Paris, France.
    Int J Tuberc Lung Dis. 2020;24:428-435.
    PubMed     Abstract available


  21. TOMENY EM, Mendoza VL, Marcelo DB, Barrameda AJD, et al
    Patient-cost survey for tuberculosis in the context of patient-pathway modelling.
    Int J Tuberc Lung Dis. 2020;24:420-427.
    PubMed     Abstract available


  22. O'SON L, Hulland E, Cookson ST, Castro KG, et al
    Epidemiology and risk factors for extrapulmonary tuberculosis in Lebanon.
    Int J Tuberc Lung Dis. 2020;24:414-419.
    PubMed     Abstract available


  23. GOBAUD AN, Haley CA, Wilson JW, Bhavaraju R, et al
    Multidrug-resistant tuberculosis care in the United States.
    Int J Tuberc Lung Dis. 2020;24:409-413.
    PubMed     Abstract available


  24. MCCREESH N, Grant AD, Yates TA, Karat AS, et al
    Tuberculosis from transmission in clinics in high HIV settings may be far higher than contact data suggest.
    Int J Tuberc Lung Dis. 2020;24:403-408.
    PubMed     Abstract available


  25. KIM HY, Hanrahan CF, Dowdy DW, Martinson NA, et al
    Priorities among HIV-positive individuals for tuberculosis preventive therapies.
    Int J Tuberc Lung Dis. 2020;24:396-402.
    PubMed     Abstract available


  26. MASUKU SD, Berhanu R, Van Rensburg C, Ndjeka N, et al
    Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis.
    Int J Tuberc Lung Dis. 2020;24:376-382.
    PubMed     Abstract available


  27. MILLER CR, Mitchell EMH, Nishikiori N, Zwerling A, et al
    ScreenTB: a tool for prioritising risk groups and selecting algorithms for screening for active tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:367-375.
    PubMed     Abstract available


  28. LANEY AS, Pontali E
    Computer-assisted interpretation of chest radiographs: signs of hope for silicosis and tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:362-363.
    PubMed    


  29. CRUZ AT, Schwartzman K, Kitai I
    Fighting a hidden epidemic: expanding tuberculosis preventive treatment to the youngest household contacts.
    Int J Tuberc Lung Dis. 2020;24:357-359.
    PubMed    


    March 2020
  30. HASKER E, Assoumani Y, Mzembaba A, Zakir AM, et al
    Using a geographic information system as a management tool for tuberculosis control.
    Int J Tuberc Lung Dis. 2020;24:354-356.
    PubMed    


  31. YATES TA, Tomlinson LA, Douglas IJ
    Proton pump inhibitors and tuberculosis risk.
    Int J Tuberc Lung Dis. 2020;24:353-354.
    PubMed    


  32. KOHLENBERG A, Kodmon C, van den Boom M, van der Werf MJ, et al
    Tuberculosis surveillance in adolescents: what to learn from European Union/European Economic Area data?
    Int J Tuberc Lung Dis. 2020;24:347-352.
    PubMed     Abstract available


  33. GUNASEKERA K, Cohen T, Gao W, Ayles H, et al
    Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey.
    Int J Tuberc Lung Dis. 2020;24:340-346.
    PubMed     Abstract available


  34. NGABONZIZA JS, Habimana YM, Decroo T, Migambi P, et al
    Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda.
    Int J Tuberc Lung Dis. 2020;24:329-339.
    PubMed     Abstract available


  35. BONSU F, Addo KK, Alebachew Z, Gyapong J, et al
    National population-based tuberculosis prevalence survey in Ghana, 2013.
    Int J Tuberc Lung Dis. 2020;24:321-328.
    PubMed     Abstract available


  36. JANSSON L, Shedrawy J, Lonnroth K, Bruchfeld J, et al
    Latent tuberculosis in pregnant women: a patient perspective.
    Int J Tuberc Lung Dis. 2020;24:310-315.
    PubMed     Abstract available


  37. LOPEZ-MEDINA EM, Sainz T, de Ory SJ, Mellado-Pena MJ, et al
    Tuberculosis in a Spanish cohort of children living with HIV: the CHOTIS study (Childhood HIV & TB study).
    Int J Tuberc Lung Dis. 2020;24:303-309.
    PubMed     Abstract available


  38. WANG M, Liu F, Li Q, Yin Q, et al
    Quality assessment of guidelines for the management of Mycobacterium tuberculosis infection in children.
    Int J Tuberc Lung Dis. 2020;24:287-294.
    PubMed     Abstract available


  39. ARNEDO-PENA A, Juan-Cerdan JV, Romeu-Garcia M, Sorribes-Segura S, et al
    Vitamin D status and latent tuberculosis infection: conversion in nursing homes, Spain.
    Int J Tuberc Lung Dis. 2020;24:278-286.
    PubMed     Abstract available


  40. REICHLER MR, Hirsch-Moverman Y
    Antenatal diagnosis of latent tuberculosis infection and post-partum treatment: patient perspectives.
    Int J Tuberc Lung Dis. 2020;24:266-267.
    PubMed    


  41. DEDICOAT M
    Where next with for vitamin D and tuberculosis?
    Int J Tuberc Lung Dis. 2020;24:265.
    PubMed    


  42. DOWDY DW
    The urgent need to improve clinical practice guidelines for pediatric tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:264.
    PubMed    


    February 2020
  43. SINGH AR, Shewade HD, Pandey R
    Near real-time supervision of home visits for patients with tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:260-261.
    PubMed    


  44. TALBOT EA
    Response to Dr Granich's letter regarding 'Tackling drug-resistant tuberculosis: we need a critical synergy of product and process innovations'.
    Int J Tuberc Lung Dis. 2020;24:259.
    PubMed    


  45. PARWATI CG, Farid MN, Nasution HS, Basri C, et al
    Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia.
    Int J Tuberc Lung Dis. 2020;24:250-257.
    PubMed     Abstract available


  46. PARK S, Jo KW, Shim TS
    Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility.
    Int J Tuberc Lung Dis. 2020;24:233-239.
    PubMed     Abstract available


  47. QUISPE N, Asencios L, Obregon C, Velasquez GE, et al
    The fourth national anti-tuberculosis drug resistance survey in Peru.
    Int J Tuberc Lung Dis. 2020;24:207-213.
    PubMed     Abstract available


  48. GATTI A, Ceriani C, De Paschale M, Magnani C, et al
    Quantification of neutrophil and monocyte CD64 expression: a predictive biomarker for active tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:196-201.
    PubMed     Abstract available


  49. WANG EY, Arrazola RA, Mathema B, Ahluwalia IB, et al
    The impact of smoking on tuberculosis treatment outcomes: a meta-analysis.
    Int J Tuberc Lung Dis. 2020;24:170-175.
    PubMed     Abstract available


  50. RABKIN M, Howard AA, Ehrenkranz P, Fernandez LG, et al
    Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action.
    Int J Tuberc Lung Dis. 2020;24:165-169.
    PubMed     Abstract available


    January 2020
  51. WU MY, Shu CC, Lin HH
    Authors reply to letter to the Editor "Chronic kidney disease, tuberculosis and climate change".
    Int J Tuberc Lung Dis. 2020;24:133-134.
    PubMed    


  52. HARRIES AD
    Chronic kidney disease, tuberculosis and climate change.
    Int J Tuberc Lung Dis. 2020;24:132-133.
    PubMed    


  53. LEROLLE N, Laanani M, Galicier L, Riviere S, et al
    Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study.
    Int J Tuberc Lung Dis. 2020;24:124-130.
    PubMed     Abstract available


  54. LINH NN, Wares F, Cocozza AM, Uplekar M, et al
    No universal access to drug-resistant tuberculosis care without engaging all health care providers.
    Int J Tuberc Lung Dis. 2020;24:118-123.
    PubMed     Abstract available


  55. DESHMUKH S, Atre S, Chavan A, Raskar S, et al
    Assessment of the Xpert assay among adult pulmonary tuberculosis suspects with and without diabetes mellitus.
    Int J Tuberc Lung Dis. 2020;24:113-117.
    PubMed     Abstract available


  56. BARSS L, Moayedi-Nia S, Campbell JR, Oxlade O, et al
    Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2020;24:100-109.
    PubMed     Abstract available


  57. CHEN MP, Miramontes R, Kammerer JS
    Multidrug-resistant tuberculosis in the United States, 2011-2016: patient characteristics and risk factors.
    Int J Tuberc Lung Dis. 2020;24:92-99.
    PubMed     Abstract available


  58. HILL J, Dickson-Hall L, Grant AD, Grundy C, et al
    Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data.
    Int J Tuberc Lung Dis. 2020;24:83-91.
    PubMed     Abstract available


  59. RAGAN EJ, Kleinman MB, Sweigart B, Gnatienko N, et al
    The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2020;24:73-82.
    PubMed     Abstract available


  60. HONG H, Dowdy DW, Dooley KE, Francis HW, et al
    Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.
    Int J Tuberc Lung Dis. 2020;24:65-72.
    PubMed     Abstract available


  61. PERUMAL R, Naidoo K, Naidoo A, Ramachandran G, et al
    A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes.
    Int J Tuberc Lung Dis. 2020;24:48-64.
    PubMed     Abstract available


  62. COCOZZA AM, Linh NN, Nathavitharana RR, Ahmad U, et al
    An assessment of current tuberculosis patient care and support policies in high-burden countries.
    Int J Tuberc Lung Dis. 2020;24:36-42.
    PubMed     Abstract available


  63. REEVES H, Grandjean Lapierre S, Razafindrina K, Andriamiadanarivo A, et al
    Evaluating the use of educational videos to support the tuberculosis care cascade in remote Madagascar.
    Int J Tuberc Lung Dis. 2020;24:28-35.
    PubMed     Abstract available


  64. GUTIERREZ C, Somoskovi A
    Serum levels of tuberculosis drugs-beyond the quantitative data.
    Int J Tuberc Lung Dis. 2020;24:6-7.
    PubMed    


  65. CHAULK CP, Moonan PK
    Over the limit: tuberculosis and excessive alcohol use.
    Int J Tuberc Lung Dis. 2020;24:3-4.
    PubMed    


    December 2019
  66. DENHOLM JT, Leontiou C, McKeown A, Watts KN, et al
    Speaking up: language services, tuberculosis and human rights.
    Int J Tuberc Lung Dis. 2019;23:1336.
    PubMed    


  67. MEKONNEN D, Derbie A, Abeje A, Shumet A, et al
    Genomic diversity and transmission dynamics of M. tuberculosis in Africa: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:1314-1326.
    PubMed     Abstract available


  68. SURIE D, Interrante JD, Pathmanathan I, Patel MR, et al
    Policies, practices and barriers to implementing tuberculosis preventive treatment-35 countries, 2017.
    Int J Tuberc Lung Dis. 2019;23:1308-1313.
    PubMed     Abstract available


  69. LIFAN Z, Sainan B, Feng S, Siyan Z, et al
    Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:1293-1307.
    PubMed     Abstract available


  70. HANDEL A, Martinez L, Sekandi JN, Bellan SE, et al
    Evidence for supercoughers in an analysis of six tuberculosis cohorts from China, Peru, The Gambia and Uganda.
    Int J Tuberc Lung Dis. 2019;23:1286-1292.
    PubMed     Abstract available


  71. ZMAK L, Obrovac M, Makek MJ, Perko G, et al
    From Peruvian mummies to living humans: first case of pulmonary tuberculosis caused by Mycobacterium pinnipedii.
    Int J Tuberc Lung Dis. 2019;23:1283-1285.
    PubMed     Abstract available


  72. SOH AZ, Chee CBE, Wang YT, Yuan JM, et al
    Diabetes and body mass index in relation to risk of active tuberculosis: a prospective population-based cohort.
    Int J Tuberc Lung Dis. 2019;23:1277-1282.
    PubMed     Abstract available


  73. PENG Y, Zhu Y, Ao G, Chen Z, et al
    Effect of bronchial artery embolisation on the management of tuberculosis-related haemoptysis.
    Int J Tuberc Lung Dis. 2019;23:1269-1276.
    PubMed     Abstract available


  74. WADEMAN DT, Busakwe L, Nicholson TJ, van der Zalm M, et al
    Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial.
    Int J Tuberc Lung Dis. 2019;23:1263-1268.
    PubMed     Abstract available


  75. CHANDAK RJ, Malhotra B, Bhargava S, Goel SK, et al
    Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs.
    Int J Tuberc Lung Dis. 2019;23:1257-1262.
    PubMed     Abstract available


  76. DUNSTAN SJ, Williamson DA, Denholm JT
    Understanding the global tuberculosis epidemic: moving towards routine whole-genome sequencing.
    Int J Tuberc Lung Dis. 2019;23:1241-1242.
    PubMed    


  77. HARRIES AD
    Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:1237-1238.
    PubMed    


  78. SUDBURY E, Villanueva P, Goetzinger F, Tebruegge M, et al
    The impact of bacille Calmette-Guerin vaccination on tuberculin skin test results in young children.
    Int J Tuberc Lung Dis. 2019;23:1335-1336.
    PubMed    


    November 2019
  79. HARRIES AD, Dlodlo RA, Brigden G, Mortimer K, et al
    Should we consider a 'fourth 90' for tuberculosis?
    Int J Tuberc Lung Dis. 2019 Nov 21. doi: 10.5588/ijtld.19.0471.
    PubMed     Abstract available


  80. TIMIRE C, Sandy C, Harries AD
    Eliminating tuberculosis by 2035: tackling the financial barriers at all stages of the cascade of care.
    Int J Tuberc Lung Dis. 2019;23:1235.
    PubMed    


  81. COIT J, Mendoza M, Pinedo C, Marin H, et al
    Performance of a household tuberculosis exposure survey among children in a Latin American setting.
    Int J Tuberc Lung Dis. 2019;23:1223-1227.
    PubMed     Abstract available


  82. RIVERA VR, Lu L, Ocheretina O, Jean Juste MA, et al
    Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti.
    Int J Tuberc Lung Dis. 2019;23:1217-1222.
    PubMed     Abstract available


  83. SUMALANI KK, Akhter N, Chawla D, Rizvi NA, et al
    Diagnostic yield of sputum induction in patients with pleural tuberculosis at a tertiary care hospital in Karachi.
    Int J Tuberc Lung Dis. 2019;23:1213-1216.
    PubMed     Abstract available


  84. ERLINGER S, Stracker N, Hanrahan C, Nonyane S, et al
    Tuberculosis patients with higher levels of poverty face equal or greater costs of illness.
    Int J Tuberc Lung Dis. 2019;23:1205-1212.
    PubMed     Abstract available


  85. JORDAN AM, Podewils LJ, Castro KG, Zishiri V, et al
    Prevalence and risk factors of tuberculosis disease in South African correctional facilities in 2015.
    Int J Tuberc Lung Dis. 2019;23:1198-1204.
    PubMed     Abstract available


  86. VINEY K, Amaral S, Marques EB, Siroka A, et al
    Four of five tuberculosis patients experience catastrophic costs related to TB diagnosis and care in Timor-Leste.
    Int J Tuberc Lung Dis. 2019;23:1191-1197.
    PubMed     Abstract available


  87. AUGUSTE P, Madan J, Tsertsvadze A, Court R, et al
    Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy.
    Int J Tuberc Lung Dis. 2019;23:1178-1190.
    PubMed     Abstract available


  88. CADMUS S, Akinseye VO, van Soolingen D
    Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975-2014.
    Int J Tuberc Lung Dis. 2019;23:1162-1170.
    PubMed     Abstract available


  89. SCHULMAN H, Niward K, Abate E, Idh J, et al
    Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:1155-1161.
    PubMed     Abstract available


  90. LAM CK, Fluegge K, Macaraig M, Burzynski J, et al
    Cost savings associated with video directly observed therapy for treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:1149-1154.
    PubMed     Abstract available


  91. BOCCIA D, Bond V
    The catastrophic cost of tuberculosis: advancing research and solutions.
    Int J Tuberc Lung Dis. 2019;23:1129-1130.
    PubMed    


  92. SCHON T
    The evaluation of routine immunological tests to estimate the risk of progression into active tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:1127-1128.
    PubMed    


  93. PEDRAZZOLI D, Houben R, Viney K, Lonnroth K, et al
    Beyond measurement: taking bold multisector actions towards zero catastrophic costs and suffering due to TB.
    Int J Tuberc Lung Dis. 2019;23:1236.
    PubMed    


    October 2019
  94. FIOGBE AA, Agodokpessi G, Marcy O
    In reply to: Programmatic implementation of screening and management of pulmonary impairment post-tuberculosis in resource-limited countries: challenges and feasibility.
    Int J Tuberc Lung Dis. 2019;23:1123.
    PubMed    


  95. OLIVEIRA MCB, Sant'Anna CC, Luiz RR, Soares ECC, et al
    Contribution of Xpert MTB/RIF to clinical diagnosis in adolescents with tuberculosis in Rio de Janeiro, Brazil.
    Int J Tuberc Lung Dis. 2019;23:1115-1121.
    PubMed     Abstract available


  96. CAMELIQUE O, Scholtissen S, Dousset JP, Bonnet M, et al
    Mobile community-based active case-finding for tuberculosis among older populations in rural Cambodia.
    Int J Tuberc Lung Dis. 2019;23:1107-1114.
    PubMed     Abstract available


  97. VALVI C, Chandanwale A, Khadse S, Kulkarni R, et al
    Delays and barriers to early treatment initiation for childhood tuberculosis in India.
    Int J Tuberc Lung Dis. 2019;23:1090-1099.
    PubMed     Abstract available


  98. BHERING M, Kritski A, Nunes C, Duarte R, et al
    Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000-2014.
    Int J Tuberc Lung Dis. 2019;23:1075-1081.
    PubMed     Abstract available


  99. COURT R, Chirehwa MT, Wiesner L, de Vries N, et al
    Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:1068-1074.
    PubMed     Abstract available


  100. BASTARD M, Sanchez-Padilla E, Hayrapetyan A, Kimenye K, et al
    What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?
    Int J Tuberc Lung Dis. 2019;23:1060-1067.
    PubMed     Abstract available


  101. VINEY K, Mills T, Harley D
    Tuberculosis and diabetes mellitus: a dose-response relationship between the odds of tuberculosis and HbA1c.
    Int J Tuberc Lung Dis. 2019;23:1055-1059.
    PubMed     Abstract available


  102. GUGLIELMETTI L, Jaffre J, Bernard C, Brossier F, et al
    Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.
    Int J Tuberc Lung Dis. 2019;23:1050-1054.
    PubMed     Abstract available


  103. PONTALI E, Tadolini M, Migliori GB
    TB consilia and quality of tuberculosis management.
    Int J Tuberc Lung Dis. 2019;23:1048-1049.
    PubMed    


  104. DOWDY DW
    Implementation of Xpert((R)) MTB/RIF: real challenges, real promise.
    Int J Tuberc Lung Dis. 2019;23:1123.
    PubMed    


  105. TADYANEMHANDU C, Garvey C, Chin A, Metcalfe J, et al
    More should be done now for patients with TB-associated chronic lung disease.
    Int J Tuberc Lung Dis. 2019;23:1122-1123.
    PubMed    


  106. JINDAL SK
    Searching for a mole in the hill.
    Int J Tuberc Lung Dis. 2019;23:1047.
    PubMed    


    September 2019
  107. VANINO E, Tadolini M, Attard L, Cascavilla A, et al
    A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care.
    Int J Tuberc Lung Dis. 2019;23:1042.
    PubMed    


  108. GALEGO MA, Santos JV, Viana J, Freitas A, et al
    To be or not to be hospitalised with tuberculosis in Portugal.
    Int J Tuberc Lung Dis. 2019;23:1029-1034.
    PubMed     Abstract available


  109. DI BELLA S, Siroka A, Antonello RM, Zignol M, et al
    Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country.
    Int J Tuberc Lung Dis. 2019;23:1024-1028.
    PubMed     Abstract available


  110. HUGHES J, Reuter A, Chabalala B, Isaakidis P, et al
    Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting.
    Int J Tuberc Lung Dis. 2019;23:1017-1023.
    PubMed     Abstract available


  111. PEREA-JACOBO R, Muniz-Salazar R, Laniado-Laborin R, Cabello-Pasini A, et al
    Rifampin pharmacokinetics in tuberculosis-diabetes mellitus patients: a pilot study from Baja California, Mexico.
    Int J Tuberc Lung Dis. 2019;23:1012-1016.
    PubMed     Abstract available


  112. BUZIASHVILI M, Mirtskhulava V, Kipiani M, Blumberg HM, et al
    Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia.
    Int J Tuberc Lung Dis. 2019;23:1005-1011.
    PubMed     Abstract available


  113. OTA M, Uchimura K
    Trends of tuberculosis rates before and after the declaration as a public health emergency in Japan, 1992-2006.
    Int J Tuberc Lung Dis. 2019;23:1000-1004.
    PubMed     Abstract available


  114. HELD K, McAnaw S, Chiang CY, Trebucq A, et al
    Progress in global rollout of new multidrug-resistant tuberculosis treatments.
    Int J Tuberc Lung Dis. 2019;23:996-999.
    PubMed     Abstract available


  115. ZHANG HC, Ruan QL, Wu J, Zhang S, et al
    Serial T-SPOT.TB in household contacts of tuberculosis patients: a 6-year observational study in China.
    Int J Tuberc Lung Dis. 2019;23:989-995.
    PubMed     Abstract available


  116. FARLEY JE, McKenzie-White J, Bollinger R, Hong H, et al
    Evaluation of miLINC to shorten time to treatment for rifampicin-resistant Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:980-988.
    PubMed     Abstract available


  117. SMITTIPAT N, Miyahara R, Juthayothin T, Billamas P, et al
    Indo-Oceanic Mycobacterium tuberculosis strains from Thailand associated with higher mortality.
    Int J Tuberc Lung Dis. 2019;23:972-979.
    PubMed     Abstract available


  118. MISHRA B, Mohapatra PR
    Expand the RRDR hotspot to improve GeneXpert results.
    Int J Tuberc Lung Dis. 2019;23:1043.
    PubMed    


  119. HARRIES AD, Chakaya JM
    Assessing and managing pulmonary impairment in those who have completed TB treatment in programmatic settings.
    Int J Tuberc Lung Dis. 2019;23:1044-1045.
    PubMed    


  120. HARRIES AD, Timire C, Takarinda KC, Sandy C, et al
    Ensuring that Xpert((R)) MTB/RIF is used to its maximum potential.
    Int J Tuberc Lung Dis. 2019;23:1043-1044.
    PubMed    


    August 2019
  121. FRANKE MF, Rodriguez CA, Mitnick CD
    Causal inference in tuberculosis treatment studies: bias considerations and data needs.
    Int J Tuberc Lung Dis. 2019;23:960-961.
    PubMed    


  122. FURIN J, Frick M, McKenna L
    A human rights-based approach to tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2019;23:959.
    PubMed    


  123. VAN DEUN A, Tahseen S, Affolabi D, Hossain MA, et al
    In reply: A human rights-based approach to tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2019;23:959-960.
    PubMed    


  124. SONG HJ, Park H, Seo HJ
    Association between use of proton pump inhibitors and tuberculosis risk: a systematic review.
    Int J Tuberc Lung Dis. 2019;23:943-951.
    PubMed     Abstract available


  125. SUN Y, Gao L, Xia H, Yang Z, et al
    Accuracy of molecular diagnostic tests for drug-resistant tuberculosis detection in China: a systematic review.
    Int J Tuberc Lung Dis. 2019;23:931-942.
    PubMed     Abstract available


  126. PARK S, Yang BR, Song HJ, Jang SH, et al
    Metformin and tuberculosis risk in elderly patients with diabetes mellitus.
    Int J Tuberc Lung Dis. 2019;23:924-930.
    PubMed     Abstract available


  127. GURJAV U, Ankhbat M, Ganbaatar G, Batjarga K, et al
    Vitamin D deficiency is associated with tuberculosis infection among household contacts in Ulaanbaatar, Mongolia.
    Int J Tuberc Lung Dis. 2019;23:919-923.
    PubMed     Abstract available


  128. TAHSEEN S, Ambreen A, Masood F, Qadir M, et al
    Primary drug resistance in extra-pulmonary tuberculosis: a hospital-based prospective study from Pakistan.
    Int J Tuberc Lung Dis. 2019;23:900-906.
    PubMed     Abstract available


  129. MARX FM, Cohen T, Lombard C, Hesseling AC, et al
    Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa.
    Int J Tuberc Lung Dis. 2019;23:891-899.
    PubMed     Abstract available


  130. KRAKAUER EL, Dheda K, Kalsdorf B, Kuksa L, et al
    Palliative care and symptom relief for people affected by multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:881-890.
    PubMed     Abstract available


  131. CHESOV D, Lange C, Heyckendorf J
    Molecular-based tuberculosis drug susceptibility testing: one size fits all?
    Int J Tuberc Lung Dis. 2019;23:879-880.
    PubMed    


    July 2019
  132. MORASERT T
    In reply to Comments on "Prevalence and risk factors associated with tuberculosis disease in Suratthani Central Prison, Thailand".
    Int J Tuberc Lung Dis. 2019;23:874-875.
    PubMed    


  133. COX SN, Elf JL, Lokhande R, Ogale YP, et al
    Mobile phone access and comfort: implications for HIV and tuberculosis care in India and South Africa.
    Int J Tuberc Lung Dis. 2019;23:865-872.
    PubMed     Abstract available


  134. RUSWA N, Mavhunga F, Roscoe JC, Beukes A, et al
    Second nationwide anti-tuberculosis drug resistance survey in Namibia.
    Int J Tuberc Lung Dis. 2019;23:858-864.
    PubMed     Abstract available


  135. LEE M, Han J, Kim YR, Kwak N, et al
    Multidrug-resistant tuberculosis in South Korea: a retrospective analysis of national registry data in 2011-2015.
    Int J Tuberc Lung Dis. 2019;23:850-857.
    PubMed     Abstract available


  136. YUEN CM, Agaya J, Mchembere W, Okelloh D, et al
    Optimizing the efficiency of tuberculosis active case-finding in health facilities and communities.
    Int J Tuberc Lung Dis. 2019;23:844-849.
    PubMed     Abstract available


  137. IRFAN S, Rao N, Irfan M, Iftikhar I, et al
    Utility of the microcolony method for evaluation of multidrug-resistant tuberculosis patients in Karachi, Pakistan.
    Int J Tuberc Lung Dis. 2019;23:838-843.
    PubMed     Abstract available


  138. BOGDANOVA E, Mariandyshev O, Hinderaker SG, Nikishova E, et al
    Mass screening for active case finding of pulmonary tuberculosis in the Russian Federation: how to save costs.
    Int J Tuberc Lung Dis. 2019;23:830-837.
    PubMed     Abstract available


  139. SGRO A, Ots R, Brunetti E
    Impact of World Tuberculosis Day on digital awareness of tuberculosis: analyses using Google Trends.
    Int J Tuberc Lung Dis. 2019;23:824-829.
    PubMed     Abstract available


  140. PHILIPSEN RHHM, Sanchez CI, Melendez J, Lew WJ, et al
    Automated chest X-ray reading for tuberculosis in the Philippines to improve case detection: a cohort study.
    Int J Tuberc Lung Dis. 2019;23:805-810.
    PubMed     Abstract available


  141. ARMSTRONG LR, Winston CA, Stewart B, Tsang CA, et al
    Changes in tuberculosis epidemiology, United States, 1993-2017.
    Int J Tuberc Lung Dis. 2019;23:797-804.
    PubMed     Abstract available


  142. HUANGFU P, Ugarte-Gil C, Golub J, Pearson F, et al
    The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:783-796.
    PubMed     Abstract available


  143. TALBOT EA, Pai M
    Tackling drug-resistant tuberculosis: we need a critical synergy of product and process innovations.
    Int J Tuberc Lung Dis. 2019;23:774-782.
    PubMed     Abstract available


  144. DEDICOAT M
    Tuberculosis control in the United States: strengths, weaknesses, opportunities, threats.
    Int J Tuberc Lung Dis. 2019;23:773.
    PubMed    


  145. LIN Y, Harries AD, Kumar AMV, Critchley JA, et al
    Tackling diabetes mellitus and tuberculosis: a new Union guide on the management of diabetes-tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:771-772.
    PubMed    


  146. MARTINEZ-GIRON R, van Woerden HC
    The recognition of Lophomonas blattarum in fresh respiratory samples in recent correspondence.
    Int J Tuberc Lung Dis. 2019;23:873-874.
    PubMed    


  147. SILVA A, Ponte C, Antas PRZ
    What a difference a strain makes!
    Int J Tuberc Lung Dis. 2019;23:874.
    PubMed    


  148. NDAKIDEMI E, Emerson C, Medley A, Ngowi B, et al
    Health care worker perspectives on TB case finding and HIV services among pediatric TB patients in Tanzania.
    Int J Tuberc Lung Dis. 2019;23:811-816.
    PubMed     Abstract available


    June 2019
  149. DEL CASTILLO HX, Munive RA, Araujo-Castillo RV
    Comments on "Prevalence and risk factors associated with tuberculosis disease in Suratthani Central Prison, Thailand".
    Int J Tuberc Lung Dis. 2019;23:768-769.
    PubMed    


  150. CASTELLANOS ME, Martinez L, Whalen CC
    In reply to 'Interferon-gamma release assays have suboptimal sensitivity in both latent and active tuberculosis'.
    Int J Tuberc Lung Dis. 2019;23:767.
    PubMed    


  151. GOETZINGER F, Burkhardt I, Villanueva P, Clifford V, et al
    Interferon-gamma release assays have suboptimal sensitivity in both latent and active tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:766-767.
    PubMed    


  152. STRACKER N, Hanrahan C, Mmolawa L, Nonyane B, et al
    Risk factors for catastrophic costs associated with tuberculosis in rural South Africa.
    Int J Tuberc Lung Dis. 2019;23:756-763.
    PubMed     Abstract available


  153. VYAS A, Creswell J, Codlin AJ, Stevens R, et al
    Community-based active case-finding to reach the most vulnerable: tuberculosis in tribal areas of India.
    Int J Tuberc Lung Dis. 2019;23:750-755.
    PubMed     Abstract available


  154. TOLA HH, Holakouie-Naieni K, Tesfaye E, Mansournia MA, et al
    Prevalence of tuberculosis treatment non-adherence in Ethiopia: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:741-749.
    PubMed     Abstract available


  155. LI B, Zhang X, Guo J, Wang J, et al
    Prevalence of pulmonary tuberculosis in Tibet Autonomous Region, China, 2014.
    Int J Tuberc Lung Dis. 2019;23:735-740.
    PubMed     Abstract available


  156. PETERSON ML, Gandhi NR, Clennon J, Nelson KN, et al
    Extensively drug-resistant tuberculosis 'hotspots' and sociodemographic associations in Durban, South Africa.
    Int J Tuberc Lung Dis. 2019;23:720-727.
    PubMed     Abstract available


  157. GAUTAM H, Singla M, Jain R, Lodha R, et al
    Point-of-care urine lipoarabinomannan antigen detection for diagnosis of tuberculosis in children.
    Int J Tuberc Lung Dis. 2019;23:714-719.
    PubMed     Abstract available


  158. LALOR MK, Perkins S, Thomas HL
    Burden of multidrug-resistant tuberculosis in England: a focus on prevalent cases.
    Int J Tuberc Lung Dis. 2019;23:707-713.
    PubMed     Abstract available


  159. HAN S, Yoon SH, Goo JM, Yim JJ, et al
    Radiological features and progression of incipient active pulmonary tuberculosis according to risk factors.
    Int J Tuberc Lung Dis. 2019;23:698-706.
    PubMed     Abstract available


  160. HU T, Xu Y, Song Y, Xia X, et al
    Mitochondrial DNA haplogroup C4 can increase the risk of active tuberculosis disease in Southwest China.
    Int J Tuberc Lung Dis. 2019;23:692-697.
    PubMed     Abstract available


  161. JIANG Q, Ji L, Qiu Y, Su X, et al
    A randomised controlled trial of stepwise sputum collection to increase yields of confirmed tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:685-691.
    PubMed     Abstract available


  162. MARTINEZ N, Kornfeld H
    Tuberculosis and diabetes: from bench to bedside and back.
    Int J Tuberc Lung Dis. 2019;23:669-677.
    PubMed     Abstract available


  163. BAO J, Sha W, Zhang WH, Zhang T, et al
    Curbing the diabetes and tuberculosis co-epidemic: the potential role of China.
    Int J Tuberc Lung Dis. 2019;23:663-668.
    PubMed     Abstract available


  164. LANGE C, Aarnoutse RE, Alffenaar JWC, Bothamley G, et al
    Management of patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:645-662.
    PubMed     Abstract available


  165. VAN DEN HOF S
    Hotspots for transmission of extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:643-644.
    PubMed    


  166. DIAS HMY, Stallworthy G, Pai M
    A roadmap to engage all care providers in tuberculosis prevention and care.
    Int J Tuberc Lung Dis. 2019;23:641-642.
    PubMed    


  167. KAMAT AS, Gretschel A, Vlok AJ, Solomons R, et al
    Reply to "Cerebrospinal fluid protein and shunt obstruction in tuberculous meningitis".
    Int J Tuberc Lung Dis. 2019;23:767-768.
    PubMed    


  168. FIGAJI A, Fieggen G, Enslin N, Taylor A, et al
    Cerebrospinal fluid protein and shunt obstruction in tuberculous meningitis.
    Int J Tuberc Lung Dis. 2019;23:765.
    PubMed    


  169. ASSEFA Y, Woldeyohannes S, Gelaw YA, Hamada Y, et al
    Screening tools to exclude active pulmonary TB in high TB burden countries: systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:728-734.
    PubMed     Abstract available


    May 2019
  170. BROZ J, Jarosova B, Salih SFA, Brabec M, et al
    Association between diabetes mellitus and mortality among patients with tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:638.
    PubMed    


  171. NGUYEN CH, Pascopella L, Barry PM
    Response to IJTLD 11-18-0796 correspondence by J Broz, B Jarosova, S F A Salih, M Brabec, F M A Salih related to 'Association between diabetes mellitus and mortality among patients with tuberculosis in California, 2010-2014'.
    Int J Tuberc Lung Dis. 2019;23:638-639.
    PubMed    


  172. SCHWOEBEL V, Chiang CY, Trebucq A, Piubello A, et al
    Outcome definitions for multidrug-resistant tuberculosis treated with shorter treatment regimens.
    Int J Tuberc Lung Dis. 2019;23:619-624.
    PubMed     Abstract available


  173. HELDAL E, Dlodlo RA, Mlilo N, Nyathi BB, et al
    Local staff making sense of their tuberculosis data: key to quality care and ending tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:612-618.
    PubMed     Abstract available


  174. SWEETLAND AC, Galea J, Shin SS, Driver C, et al
    Integrating tuberculosis and mental health services: global receptivity of national tuberculosis program directors.
    Int J Tuberc Lung Dis. 2019;23:600-605.
    PubMed     Abstract available


  175. WHITEHOUSE ER, Perrin N, Levitt N, Hill M, et al
    Cardiovascular risk prevalence in South Africans with drug-resistant tuberculosis: a cross-sectional study.
    Int J Tuberc Lung Dis. 2019;23:587-593.
    PubMed     Abstract available


  176. USEMANN J, Ledergerber M, Fink G, Ritz N, et al
    Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country.
    Int J Tuberc Lung Dis. 2019;23:579-586.
    PubMed     Abstract available


  177. BUNYASI EW, Geldenhuys H, Mulenga H, Shenje J, et al
    Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents.
    Int J Tuberc Lung Dis. 2019;23:571-578.
    PubMed     Abstract available


  178. CHO PJ, Wu CY, Johnston J, Wu MY, et al
    Progression of chronic kidney disease and the risk of tuberculosis: an observational cohort study.
    Int J Tuberc Lung Dis. 2019;23:555-562.
    PubMed     Abstract available


  179. ALLWOOD BW, Rigby J, Griffith-Richards S, Kanarek D, et al
    Histologically confirmed tuberculosis-associated obstructive pulmonary disease.
    Int J Tuberc Lung Dis. 2019;23:552-554.
    PubMed     Abstract available


  180. JARAMILLO J, Yadav R, Herrera R
    Why every word counts: towards patient- and people-centered tuberculosis care.
    Int J Tuberc Lung Dis. 2019;23:547-551.
    PubMed     Abstract available


  181. KENDALL EA, Sahu S, Pai M, Fox GJ, et al
    What will it take to eliminate drug-resistant tuberculosis?
    Int J Tuberc Lung Dis. 2019;23:535-546.
    PubMed     Abstract available


  182. RIDZON R, Castro KG
    A step forward in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:533-534.
    PubMed    


  183. FRANKE MF, Smith S
    Where there's a will, there's a way: advancing integrated care for mental health, substance use and tuberculosis disease.
    Int J Tuberc Lung Dis. 2019;23:529-530.
    PubMed    


  184. MITCHELL EMH, Heumann SG, Sprague L, Tesfaye DH, et al
    'Reservoir of infection' or 'fount of knowledge'? Forging equal partnerships and shifting power to address LTBI.
    Int J Tuberc Lung Dis. 2019;23:527-528.
    PubMed    


  185. HAROUNA SH, Ortuno-Gutierrez N, Souleymane MB, Kizito W, et al
    Short-course treatment outcomes and adverse events in adults and children-adolescents with MDR-TB in Niger.
    Int J Tuberc Lung Dis. 2019;23:625-630.
    PubMed     Abstract available


  186. ISMAIL NA, Said HM, Rodrigues C, Omar SV, et al
    Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testing.
    Int J Tuberc Lung Dis. 2019;23:594-599.
    PubMed     Abstract available


  187. BERROCAL-ALMANZA LC, Botticello J, Piotrowski H, Karnani N, et al
    Engaging with civil society to improve access to LTBI screening for new migrants in England: a qualitative study.
    Int J Tuberc Lung Dis. 2019;23:563-570.
    PubMed     Abstract available


    April 2019
  188. CHESOV D, Alexandru S, Crudu V, Ciobanu N, et al
    Failing treatment of multidrug-resistant tuberculosis: a matter of definition.
    Int J Tuberc Lung Dis. 2019;23:522-524.
    PubMed    


  189. MUSAAZI J, Sekaggya-Wiltshire C, Kiragga AN, Kalule I, et al
    Sustained positive impact on tuberculosis treatment outcomes of TB-HIV integrated care in Uganda.
    Int J Tuberc Lung Dis. 2019;23:514-521.
    PubMed     Abstract available


  190. GOLUB JE, Mok Y, Hong S, Jung KJ, et al
    Diabetes mellitus and tuberculosis in Korean adults: impact on tuberculosis incidence, recurrence and mortality.
    Int J Tuberc Lung Dis. 2019;23:507-513.
    PubMed     Abstract available


  191. KUYINU YA, Goodman OO, Odugbemi BA, Adeyeye OO, et al
    Tuberculosis infection prevention and control measures in DOTS centres in Lagos State, Nigeria.
    Int J Tuberc Lung Dis. 2019;23:474-481.
    PubMed     Abstract available


  192. SORNBOOT J, Aekplakorn W, Ramasoota P, Bualert S, et al
    Detection of airborne Mycobacterium tuberculosis complex in high-risk areas of health care facilities in Thailand.
    Int J Tuberc Lung Dis. 2019;23:465-473.
    PubMed     Abstract available


  193. HOFMANN-THIEL S, Molodtsov N, Duffner C, Kadyrov A, et al
    Capacity of Abbott RealTime MTB RIF/INH to detect rifampicin- and isoniazid-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:458-464.
    PubMed     Abstract available


  194. GUPTE AN, Selvaraju S, Paradkar M, Danasekaran K, et al
    Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:450-457.
    PubMed     Abstract available


  195. KIBUULE D, Rennie TW, Ruswa N, Mavhunga F, et al
    Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia.
    Int J Tuberc Lung Dis. 2019;23:441-449.
    PubMed     Abstract available


  196. KATO-MAEDA M, Choi JC, Jarlsberg LG, Grinsdale JA, et al
    Magnitude of Mycobacterium tuberculosis transmission among household and non-household contacts of TB patients.
    Int J Tuberc Lung Dis. 2019;23:433-440.
    PubMed     Abstract available


  197. LEE S, Lee JE, Kang JS, Lee SO, et al
    Long-term performance of the IGRA to predict and prevent active tuberculosis development in HIV-infected patients.
    Int J Tuberc Lung Dis. 2019;23:422-427.
    PubMed     Abstract available


  198. SILVA DS, Komparic A, Upshur REG, Gibson J, et al
    Provider perspectives on liberty and harm in the treatment of persons with tuberculosis and mental illness.
    Int J Tuberc Lung Dis. 2019;23:405-411.
    PubMed     Abstract available


  199. NATHAVITHARANA RR, Lederer P, Tierney DB, Nardell E, et al
    Treatment as prevention and other interventions to reduce transmission of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:396-404.
    PubMed     Abstract available


  200. CASTRO KG
    Overcoming prevailing neglect to prevent transmission of Mycobacterium tuberculosis infection in health care facilities.
    Int J Tuberc Lung Dis. 2019;23:383-384.
    PubMed    


  201. MENZIES NA, McQuaid CF, Gomez GB, Siroka A, et al
    Improving the quality of modelling evidence used for tuberculosis policy evaluation.
    Int J Tuberc Lung Dis. 2019;23:387-395.
    PubMed     Abstract available


  202. FANNING A
    Community-based directly observed therapy improves treatment success.
    Int J Tuberc Lung Dis. 2019;23:381-382.
    PubMed    


  203. KYI MS, Aung ST, Oo HN, Chongsuvivatwong V, et al
    Fully vs. partially integrated services for TB-HIV in Myanmar: a health services review and a cohort study.
    Int J Tuberc Lung Dis. 2019;23:498-506.
    PubMed     Abstract available


  204. EPSTEIN RL, Bhagavathula M, Saag LA, Verma S, et al
    QuantiFERON((R))-TB Gold In-Tube reliability for immigrants with parasitic infections in Boston, USA.
    Int J Tuberc Lung Dis. 2019;23:482-490.
    PubMed     Abstract available


    March 2019
  205. TESEMA E, Wares F, Bedru A, Negeri C, et al
    Hear this! Audiometry testing saves the hearing of a patient with drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:378-379.
    PubMed    


  206. SIFUNA PM, Ouma C, Atieli H, Owuoth J, et al
    Spatial epidemiology of tuberculosis in the high-burden counties of Kisumu and Siaya, Western Kenya, 2012-2015.
    Int J Tuberc Lung Dis. 2019;23:363-370.
    PubMed     Abstract available


  207. PHYO KH, Oo MM, Harries AD, Saw S, et al
    High prevalence and incidence of tuberculosis in people living with the HIV in Mandalay, Myanmar, 2011-2017.
    Int J Tuberc Lung Dis. 2019;23:349-357.
    PubMed     Abstract available


  208. WINGFIELD T, MacPherson P, Sodha P, Tucker A, et al
    Contacts of underserved tuberculosis patients have higher odds of TB disease in North West England: a cohort study.
    Int J Tuberc Lung Dis. 2019;23:337-343.
    PubMed     Abstract available


  209. MAKHMUDOVA M, Maxsumova Z, Rajabzoda A, Makhmadov A, et al
    Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan.
    Int J Tuberc Lung Dis. 2019;23:331-336.
    PubMed     Abstract available


  210. LO TQ, Matlhare L, Mugisha K, Lere TD, et al
    Initiation of anti-tuberculosis treatment in children following gastric aspirate testing, Botswana, 2008-2012.
    Int J Tuberc Lung Dis. 2019;23:315-321.
    PubMed     Abstract available


  211. CRABTREE-RAMIREZ B, Jenkins C, Jayathilake K, Carriquiry G, et al
    HIV-related tuberculosis: mortality risk in persons without vs. with culture-confirmed disease.
    Int J Tuberc Lung Dis. 2019;23:306-314.
    PubMed     Abstract available


  212. RICHARDSON M, Kirkham J, Dwan K, Sloan DJ, et al
    NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:293-305.
    PubMed     Abstract available


  213. HUANGFU P, Laurence YV, Alisjahbana B, Ugarte-Gil C, et al
    Point of care HbA1c level for diabetes mellitus management and its accuracy among tuberculosis patients: a study in four countries.
    Int J Tuberc Lung Dis. 2019;23:283-292.
    PubMed     Abstract available


  214. MACIAS CP, Monedero-Recuero I
    TB or not TB? Challenges in diagnosing and treating maternal and neonatal tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:280-282.
    PubMed     Abstract available


  215. NGUENHA D, Garcia JI, Cowan JF, Garcia-Basteiro AL, et al
    Spatial epidemiology for tuberculosis surveillance: a relevant add-on to routine surveillance.
    Int J Tuberc Lung Dis. 2019;23:278-279.
    PubMed    


  216. SANTOS AP, Migliori GB
    Another aetiology for tuberculosis-beyond the Mycobacterium.
    Int J Tuberc Lung Dis. 2019;23:277.
    PubMed    


  217. KWON YS, Koh WJ
    The mortality rates for tuberculosis remain high even in high-income countries.
    Int J Tuberc Lung Dis. 2019;23:275-276.
    PubMed    


  218. BERHANU RH, Schnippel K, Kularatne R, Firnhaber C, et al
    Discordant rifampicin susceptibility results are associated with Xpert((R)) MTB/RIF probe B and probe binding delay.
    Int J Tuberc Lung Dis. 2019;23:358-362.
    PubMed     Abstract available


  219. LAI J, Dememew Z, Jerene D, Abashawl A, et al
    Provider barriers to the uptake of isoniazid preventive therapy among people living with HIV in Ethiopia.
    Int J Tuberc Lung Dis. 2019;23:371-377.
    PubMed     Abstract available


  220. KURTZ T, Feil AC, Nascimento LS, de Oliveira Abreu P, et al
    Effect of neonatal bacille Calmette-Guerin on the tuberculin skin test reaction in the first 2 years of life.
    Int J Tuberc Lung Dis. 2019;23:344-348.
    PubMed     Abstract available


  221. KYAW NTT, Kumar AMV, Kyaw KWY, Satyanarayana S, et al
    IPT in people living with HIV in Myanmar: a five-fold decrease in incidence of TB disease and all-cause mortality.
    Int J Tuberc Lung Dis. 2019;23:322-330.
    PubMed     Abstract available


    February 2019
  222. ZHANG RR, Liang L, Chen WW, Wen C, et al
    ULK1 polymorphisms confer susceptibility to pulmonary tuberculosis in a Chinese population.
    Int J Tuberc Lung Dis. 2019;23:265-271.
    PubMed     Abstract available


  223. MAZZARELLI A, Cannas A, Venditti C, D'Arezzo S, et al
    Clinical evaluation of TRCReady M.TB for rapid automated detection of M. tuberculosis complex in respiratory samples.
    Int J Tuberc Lung Dis. 2019;23:260-264.
    PubMed     Abstract available


  224. HOOD G, Trieu L, Ahuja SD
    Mortality among tuberculosis patients in New York City.
    Int J Tuberc Lung Dis. 2019;23:252-259.
    PubMed     Abstract available


  225. HARRIES AD, Schwoebel V, Monedero-Recuero I, Aung TK, et al
    Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
    Int J Tuberc Lung Dis. 2019;23:241-251.
    PubMed     Abstract available


  226. GOLLI AL, Nitu MF, Turcu F, Popescu M, et al
    Tuberculosis remains a public health problem in Romania.
    Int J Tuberc Lung Dis. 2019;23:226-231.
    PubMed     Abstract available


  227. LUO J, Luo M, Li J, Yu J, et al
    Rapid direct drug susceptibility testing of Mycobacterium tuberculosis based on culture droplet digital polymerase chain reaction.
    Int J Tuberc Lung Dis. 2019;23:219-225.
    PubMed     Abstract available


  228. COELHO DA SILVA FD, Covre LP, Stringari LL, Palaci M, et al
    Toll-like receptors blocking restores in vitro microbicidal activity in latent tuberculosis-infected subjects.
    Int J Tuberc Lung Dis. 2019;23:212-218.
    PubMed     Abstract available


  229. CHIN AT, Rylance J, Makumbirofa S, Meffert S, et al
    Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study.
    Int J Tuberc Lung Dis. 2019;23:203-211.
    PubMed     Abstract available


  230. FIOGBE AA, Agodokpessi G, Tessier JF, Affolabi D, et al
    Prevalence of lung function impairment in cured pulmonary tuberculosis patients in Cotonou, Benin.
    Int J Tuberc Lung Dis. 2019;23:195-202.
    PubMed     Abstract available


  231. ENDALAMAW A, Ambachew S, Geremew D, Habtewold TD, et al
    HIV infection and unknown HIV status among tuberculosis patients in Ethiopia: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:187-194.
    PubMed     Abstract available


  232. MURAKAMI R, Matsuo N, Ueda K, Nakazawa M, et al
    Epidemiological and spatial factors for tuberculosis: a matched case-control study in Nagata, Japan.
    Int J Tuberc Lung Dis. 2019;23:181-186.
    PubMed     Abstract available


  233. KWAK N, Kim HR, Yoo CG, Kim YW, et al
    Multidrug-resistant tuberculosis over 20 years at a referral hospital in South Korea: trends and outcomes.
    Int J Tuberc Lung Dis. 2019;23:174-180.
    PubMed     Abstract available


  234. ZURITA J, Espinel N, Barba P, Ortega-Paredes D, et al
    Genetic diversity and drug resistance of Mycobacterium tuberculosis in Ecuador.
    Int J Tuberc Lung Dis. 2019;23:166-173.
    PubMed     Abstract available


  235. COX V, Cox H, Pai M, Stillo J, et al
    Health care gaps in the global burden of drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:125-135.
    PubMed     Abstract available


  236. SULEIMAN K, England K, Lessem E, McKenna L, et al
    Key features to consider in revising the Model List of Essential In Vitro Diagnostics: a TB perspective.
    Int J Tuberc Lung Dis. 2019;23:272.
    PubMed    


  237. SYKES CA, Shepherd J, McGoldrick C, Kennedy N, et al
    A case of rifampicin-induced haemolysis.
    Int J Tuberc Lung Dis. 2019;23:239-240.
    PubMed     Abstract available


  238. VAN AERDE KJ, van der Heijden EHFM, Henriet SS, Merkus PJ, et al
    A case promoting use of ultrasound-guided sampling techniques to correctly diagnose MDR-TB in children.
    Int J Tuberc Lung Dis. 2019;23:236-238.
    PubMed     Abstract available


  239. RENDON A, Silva DR, Esposito S, Sotgiu G, et al
    Launching the Global TB Network.
    Int J Tuberc Lung Dis. 2019;23:123-124.
    PubMed    


    January 2019
  240. PALEIRON N, Soler C, Hassan MO, Andriamanantena D, et al
    First description of Mycobacterium tuberculosis and M. canettii concomitant infection: report of two cases.
    Int J Tuberc Lung Dis. 2019 Jan 24. doi: 10.5588/ijtld.18.0261.
    PubMed     Abstract available


  241. HANIFA Y, Toro Silva S, Karstaedt A, Sahid F, et al
    What causes symptoms suggestive of tuberculosis in HIV-positive people with negative initial investigations?
    Int J Tuberc Lung Dis. 2019 Jan 24. doi: 10.5588/ijtld.18.0251.
    PubMed     Abstract available


  242. MOK J, Kang BH, Kim HJ, Lee SJ, et al
    Drug resistance in extra-pulmonary tuberculosis in South Korea: comparison with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0109.
    PubMed     Abstract available


  243. LE H, Nguyen N, Tran P, Hoa N, et al
    Process measure of FAST tuberculosis infection control demonstrates delay in likely effective treatment.
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0268.
    PubMed     Abstract available


  244. YE R, Wang C, Zhao L, Wu X, et al
    Characteristics of miliary tuberculosis in pregnant women after in vitro fertilisation and embryo transfer.
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0223.
    PubMed     Abstract available


  245. BHARGAVA M, Bhargava A, Akshaya KM, Shastri SG, et al
    Nutritional assessment and counselling of tuberculosis patients at primary care in India: do we measure up?
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0333.
    PubMed     Abstract available


  246. ANAGNOSTOPOULOS I, Lagou S, Papatheodoridi M, Marinos L, et al
    A rare case of bone marrow BCG-itis responding to second-line anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2019;23:119-120.
    PubMed    


  247. RAHU K, Viiklepp P, Villand K, Pehme L, et al
    Respiratory tuberculosis incidence and mortality in Estonia: 30-year trends and sociodemographic determinants.
    Int J Tuberc Lung Dis. 2019;23:112-118.
    PubMed     Abstract available


  248. YASSEEN AS, Rea E, Hirji MM, Yang C, et al
    Paediatric tuberculosis among the foreign-born: utility of the Canadian TB immigration medical surveillance programme.
    Int J Tuberc Lung Dis. 2019;23:105-111.
    PubMed     Abstract available


  249. PERRINEAU S, Lachatre M, Le MP, Rioux C, et al
    Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:99-104.
    PubMed     Abstract available


  250. LAXMESHWAR C, Stewart AG, Dalal A, Kumar AMV, et al
    Beyond 'cure' and 'treatment success': quality of life of patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:73-81.
    PubMed     Abstract available


  251. AZNAR ML, Rando-Segura A, Moreno MM, Soley ME, et al
    Prevalence and risk factors of multidrug-resistant tuberculosis in Cubal, Angola: a prospective cohort study.
    Int J Tuberc Lung Dis. 2019;23:67-72.
    PubMed     Abstract available


  252. ALEXANDER M, Gupta A, Mathad JS
    Is there a connection between gestational diabetes mellitus, human immunodeficiency virus infection, and tuberculosis?
    Int J Tuberc Lung Dis. 2019;23:19-25.
    PubMed     Abstract available


  253. DOWDY DW
    Xpert at 8 years: where are we now, and what should we do next?
    Int J Tuberc Lung Dis. 2019;23:3-4.
    PubMed    


  254. POTTER JL, White VLC
    Patients want to live, not merely survive.
    Int J Tuberc Lung Dis. 2019;23:1-2.
    PubMed    


  255. REIMANN M, Schaub D, Kalsdorf B, Runge C, et al
    Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB.
    Int J Tuberc Lung Dis. 2019;23:93-98.
    PubMed     Abstract available


  256. AGIZEW T, Boyd R, Auld AF, Payton L, et al
    Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:82-92.
    PubMed     Abstract available


  257. PEDRAZZOLI D, Borghi J, Viney K, Houben RMGJ, et al
    Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks.
    Int J Tuberc Lung Dis. 2019;23:5-11.
    PubMed     Abstract available


  258. AGGERBECK H, Ruhwald M, Hoff ST, Tingskov PN, et al
    Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial.
    Int J Tuberc Lung Dis. 2019;23:38-44.
    PubMed     Abstract available


  259. VAN DEUN A, Tahseen S, Affolabi D, Hossain MA, et al
    Sputum smear microscopy in the Xpert((R)) MTB/RIF era.
    Int J Tuberc Lung Dis. 2019;23:12-18.
    PubMed     Abstract available


    December 2018
  260. SHAH I, Jadhao N, Mali N, Deshpande S, et al
    Pharmacokinetics of isoniazid in Indian children with tuberculosis on daily treatment.
    Int J Tuberc Lung Dis. 2018 Dec 20. doi: 10.5588/ijtld.18.0463.
    PubMed     Abstract available


  261. PRATS-URIBE A, Orcau A, Millet JP, Cayla JA, et al
    Impact of socio-economic inequities on tuberculosis in a Southern European city: What is the effect of the recession?
    Int J Tuberc Lung Dis. 2018 Dec 20. doi: 10.5588/ijtld.18.0110.
    PubMed     Abstract available


  262. YU S, Shen J, Lao S, Yang B, et al
    Distinct functions of CXCR3(+) and CCR4(+)CD4(+) T-cells accumulated in human tuberculosis pleural fluid.
    Int J Tuberc Lung Dis. 2018;22:1514-1522.
    PubMed     Abstract available


  263. ASLAM MV, Owusu-Edusei K, Marks SM, Asay GRB, et al
    Number and cost of hospitalizations with principal and secondary diagnoses of tuberculosis, United States.
    Int J Tuberc Lung Dis. 2018;22:1495-1504.
    PubMed     Abstract available


  264. CHUA AP, Lim LK, Gan SH, Chee CB, et al
    The role of chronic viral hepatitis on tuberculosis treatment interruption.
    Int J Tuberc Lung Dis. 2018;22:1486-1494.
    PubMed     Abstract available


  265. PHO Y, Nhem S, Sok C, By B, et al
    Melioidosis in patients with suspected tuberculosis in Cambodia: a single-center cross-sectional study.
    Int J Tuberc Lung Dis. 2018;22:1481-1485.
    PubMed     Abstract available


  266. ZAWEDDE-MUYANJA S, Manabe YC, Sewankambo NK, Nakiyingi L, et al
    Xpert((R)) MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1475-1480.
    PubMed     Abstract available


  267. NKURUNZIZA J, Karstaedt AS, Louw R, Padanilam X, et al
    Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
    Int J Tuberc Lung Dis. 2018;22:1469-1474.
    PubMed     Abstract available


  268. GE E, Li D, Luo M, Tsui KWS, et al
    Transmission of multidrug-resistant tuberculosis in Shanghai: roles of residential status.
    Int J Tuberc Lung Dis. 2018;22:1462-1468.
    PubMed     Abstract available


  269. OPOLLO VS, Wu X, Hughes MD, Swindells S, et al
    HIV testing uptake among the household contacts of multidrug-resistant tuberculosis index cases in eight countries.
    Int J Tuberc Lung Dis. 2018;22:1443-1449.
    PubMed     Abstract available


  270. HAMADA Y, Ford N, Schenkel K, Getahun H, et al
    Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review.
    Int J Tuberc Lung Dis. 2018;22:1422-1428.
    PubMed     Abstract available


  271. VAN CREVEL R, Koesoemadinata R, Hill PC, Harries AD, et al
    Clinical management of combined tuberculosis and diabetes.
    Int J Tuberc Lung Dis. 2018;22:1404-1410.
    PubMed     Abstract available


  272. MENZIES NA, Hill AN, Cohen T, Salomon JA, et al
    The impact of migration on tuberculosis in the United States.
    Int J Tuberc Lung Dis. 2018;22:1392-1403.
    PubMed     Abstract available


  273. AUER C, Bosch-Capblanch X
    Taking tuberculosis seriously requires that we take poverty seriously: reinstating the ethics of public health.
    Int J Tuberc Lung Dis. 2018;22:1390-1391.
    PubMed    


  274. CHAKAYA J, Castro JL, Jensen PM, Fujiwara PI, et al
    A new era for global tuberculosis: holding leaders accountable for promises.
    Int J Tuberc Lung Dis. 2018;22:1387.
    PubMed    


    November 2018
  275. WELLS WA, Stallworthy G, Balsara Z
    How tuberculosis programs can navigate the world of social health insurance.
    Int J Tuberc Lung Dis. 2018 Nov 13. doi: 10.5588/ijtld.18.0289.
    PubMed     Abstract available


  276. SHAW JA, Smit DP, Griffith-Richards S, Koegelenberg CFN, et al
    Utility of routine chest radiography in ocular tuberculosis and sarcoidosis.
    Int J Tuberc Lung Dis. 2018;22:1374-1377.
    PubMed     Abstract available


  277. OBREGON G, Zevallos K, Alarcon V, Puyen ZM, et al
    Rapid drug susceptibility testing and treatment outcomes for multidrug-resistant tuberculosis in Peru.
    Int J Tuberc Lung Dis. 2018;22:1350-1357.
    PubMed     Abstract available


  278. SAWRY S, Moultrie H, Van Rie A
    Evaluation of the intensified tuberculosis case finding guidelines for children living with HIV.
    Int J Tuberc Lung Dis. 2018;22:1322-1328.
    PubMed     Abstract available


  279. ZAWEDDE-MUYANJA S, Nakanwagi A, Dongo JP, Sekadde MP, et al
    Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda.
    Int J Tuberc Lung Dis. 2018;22:1314-1321.
    PubMed     Abstract available


  280. VILLARREAL J, Alarcon V, Alarcon-Arrascue E, Moore DAJ, et al
    Tuberculosis in children treated with second-line drugs under programmatic conditions in Lima, Peru.
    Int J Tuberc Lung Dis. 2018;22:1307-1313.
    PubMed     Abstract available


  281. DE SOUZA RA, Nery JS, Rasella D, Guimaraes Pereira RA, et al
    Family health and conditional cash transfer in Brazil and its effect on tuberculosis mortality.
    Int J Tuberc Lung Dis. 2018;22:1300-1306.
    PubMed     Abstract available


  282. GIL N, Lopez L, Rodriguez D, Rondon M, et al
    Myths and realities about knowledge, attitudes and practices of household contacts of tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1293-1299.
    PubMed     Abstract available


  283. GRACIAA DS, Machaidze M, Kipiani M, Buziashvili M, et al
    A survey of the tuberculosis physician workforce in the country of Georgia.
    Int J Tuberc Lung Dis. 2018;22:1286-1292.
    PubMed     Abstract available


  284. SIMOU E, Britton J, Leonardi-Bee J
    Alcohol consumption and risk of tuberculosis: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2018;22:1277-1285.
    PubMed     Abstract available


  285. NGUYEN CH, Pascopella L, Barry PM
    Association between diabetes mellitus and mortality among patients with tuberculosis in California, 2010-2014.
    Int J Tuberc Lung Dis. 2018;22:1269-1276.
    PubMed     Abstract available


  286. MAGEE MJ, Salindri AD, Gujral UP, Auld SC, et al
    Convergence of non-communicable diseases and tuberculosis: a two-way street?
    Int J Tuberc Lung Dis. 2018;22:1258-1268.
    PubMed     Abstract available


  287. JAY SJ, Kirbiyik U, Woods JR, Steele GA, et al
    Modern theory of tuberculosis: culturomic analysis of its historical origin in Europe and North America.
    Int J Tuberc Lung Dis. 2018;22:1249-1257.
    PubMed     Abstract available


    October 2018
  288. MONEDERO-RECUERO I, Hernando-Marrupe L, Sanchez-Montalva A, Cox V, et al
    QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment.
    Int J Tuberc Lung Dis. 2018 Oct 26. doi: 10.5588/ijtld.18.0423.
    PubMed     Abstract available


  289. COMSTOCK D, Khorolsky C, Galbraith R
    Severe rifamycin-induced immune thrombocytopenia in a patient with extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1243-1244.
    PubMed    


  290. SETO J, Wada T, Suzuki Y, Ikeda T, et al
    A case of laboratory cross-contamination of Mycobacterium tuberculosis identified using comparative genomics.
    Int J Tuberc Lung Dis. 2018;22:1239-1242.
    PubMed     Abstract available


  291. WANG Y, Wang L, Wen Z, Wang J, et al
    High IL-6 and VEGF-A levels correlate with delayed wound healing in cervical lymph node tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1227-1232.
    PubMed     Abstract available


  292. ALARCON V, Alarcon-Arrascue E, Mendoza-Ticona A, Obregon G, et al
    Programmatic management of patients with pre-extensively drug-resistant tuberculosis in Peru, 2011-2014.
    Int J Tuberc Lung Dis. 2018;22:1220-1226.
    PubMed     Abstract available


  293. RIBEIRO L, Gomes M, Gaio R, Duarte R, et al
    HIV screening of tuberculosis patients in Portugal: what are we missing?
    Int J Tuberc Lung Dis. 2018;22:1216-1219.
    PubMed     Abstract available


  294. MEKONNEN A, Collins JM, Aseffa A, Ameni G, et al
    Prevalence of pulmonary tuberculosis among students in three eastern Ethiopian universities.
    Int J Tuberc Lung Dis. 2018;22:1210-1215.
    PubMed     Abstract available


  295. MORASERT T, Worapas W, Kaewmahit R, Uphala W, et al
    Prevalence and risk factors associated with tuberculosis disease in Suratthani Central Prison, Thailand.
    Int J Tuberc Lung Dis. 2018;22:1203-1209.
    PubMed     Abstract available


  296. KIZITO S, Katamba A, Marquez C, Turimumahoro P, et al
    Quality of care in childhood tuberculosis diagnosis at primary care clinics in Kampala, Uganda.
    Int J Tuberc Lung Dis. 2018;22:1196-1202.
    PubMed     Abstract available


  297. BELGAUMKAR V, Chandanwale A, Valvi C, Pardeshi G, et al
    Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1179-1187.
    PubMed     Abstract available


  298. SILVEIRA MBV, Ferrarini MAG, Viana PO, Succi RC, et al
    Contribution of the interferon-gamma release assay to tuberculosis diagnosis in children and adolescents.
    Int J Tuberc Lung Dis. 2018;22:1172-1178.
    PubMed     Abstract available


  299. PELISSARI DM, Kuhleis DC, Bartholomay P, Barreira D, et al
    Prevalence and screening of active tuberculosis in a prison in the South of Brazil.
    Int J Tuberc Lung Dis. 2018;22:1166-1171.
    PubMed     Abstract available


  300. ARMSTRONG-HOUGH M, Ggita J, Turimumahoro P, Meyer AJ, et al
    'Something so hard': a mixed-methods study of home sputum collection for tuberculosis contact investigation in Uganda.
    Int J Tuberc Lung Dis. 2018;22:1152-1159.
    PubMed     Abstract available


  301. KHAING PS, Kyaw NTT, Satyanarayana S, Oo NL, et al
    Treatment outcome of tuberculosis patients detected using accelerated vs. passive case finding in Myanmar.
    Int J Tuberc Lung Dis. 2018;22:1145-1151.
    PubMed     Abstract available


  302. HAMILTON K, Tolfree R, Mytton J
    A systematic review of active case-finding strategies for tuberculosis in homeless populations.
    Int J Tuberc Lung Dis. 2018;22:1135-1144.
    PubMed     Abstract available


  303. COHEN DB, Meghji J, Squire SB
    A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1127-1134.
    PubMed     Abstract available


  304. HARRIES AD, Lin Y, Kumar AMV, Satyanarayana S, et al
    How can integrated care and research assist in achieving the SDG targets for diabetes, tuberculosis and HIV/AIDS?
    Int J Tuberc Lung Dis. 2018;22:1117-1126.
    PubMed     Abstract available


  305. PARK J, Yim JJ
    Diagnosis of tuberculosis among children: leave no stone unturned.
    Int J Tuberc Lung Dis. 2018;22:1116.
    PubMed    


  306. AULD SC, Gandhi NR, Shah NS
    Closing the book on Category II: time for individualized regimens for patients with recurrent tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1113-1114.
    PubMed    


  307. BAO J, Hafner R, Lin Y, Lin HH, et al
    Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and research.
    Int J Tuberc Lung Dis. 2018;22:1111-1112.
    PubMed    


    September 2018
  308. FOSTER J, McBryde E, Taune M, Peniyamina D, et al
    Cross-border tuberculosis: opportunities, challenges and change.
    Int J Tuberc Lung Dis. 2018;22:1107-1108.
    PubMed    


  309. BARRETO JN, de Lourdes Monteiro M, da Luz Lima M, Valadas E, et al
    Under-reporting of tuberculosis in Praia, Cape Verde: study reports doubtful results.
    Int J Tuberc Lung Dis. 2018;22:1106.
    PubMed    


  310. KOESOEMADINATA RC, Kranzer K, Livia R, Susilawati N, et al
    Computer-assisted chest radiography reading for tuberculosis screening in people living with diabetes mellitus.
    Int J Tuberc Lung Dis. 2018;22:1088-1094.
    PubMed     Abstract available


  311. RAGHUVANSHI S, Kotwal A, Maheshwari R, Sindhwani G, et al
    Evaluation of line-probe assay for molecular analysis and drug susceptibility of extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1077-1081.
    PubMed     Abstract available


  312. GASPAR PC, Rudolf-Oliveira RCM, Wildner LM, de Moraes ACR, et al
    Evaluation of leucocytes from sputum samples of pulmonary tuberculosis patients using flow cytometry.
    Int J Tuberc Lung Dis. 2018;22:1071-1076.
    PubMed     Abstract available


  313. TAKENAMI I, de Oliveira CC, Petrilli JD, Machado A, et al
    Serum antiphospholipid antibody levels as biomarkers for diagnosis of pulmonary tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1063-1070.
    PubMed     Abstract available


  314. MYO K, Zaw M, Swe TL, Kyaw YY, et al
    Evaluation of Xpert((R)) MTB/RIF assay as a diagnostic test for pulmonary tuberculosis in children in Myanmar.
    Int J Tuberc Lung Dis. 2018;22:1051-1055.
    PubMed     Abstract available


  315. HO-FOSTER A, Tenforde MW, Arscott-Mills T, Maramba M, et al
    Risk factors for gastric aspirate culture contamination in children evaluated for tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2018;22:1044-1050.
    PubMed     Abstract available


  316. DU PREEZ K, du Plessis L, O'Connell N, Hesseling AC, et al
    Burden, spectrum and outcomes of children with tuberculosis diagnosed at a district-level hospital in South Africa.
    Int J Tuberc Lung Dis. 2018;22:1037-1043.
    PubMed     Abstract available


  317. OH CE, Kwon GY, Kwon YH, Lee EJ, et al
    High tuberculosis transmission rate in children with nursery exposure to undetected pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1031-1036.
    PubMed     Abstract available


  318. SWINDELLS S, Gupta A, Kim S, Hughes MD, et al
    Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003).
    Int J Tuberc Lung Dis. 2018;22:1016-1022.
    PubMed     Abstract available


  319. MONK EJM, Kumwenda M, Nliwasa M, Mpunga J, et al
    Factors affecting tuberculosis health message recall 2 years after active case finding in Blantyre, Malawi.
    Int J Tuberc Lung Dis. 2018;22:1007-1015.
    PubMed     Abstract available


  320. ZUUR MA, van Asselt ADI, van 't Boveneind-Vrubleuskaya N, Aleksa A, et al
    Cost-utility analysis of high-dose treatment for intermediate-susceptible, dose-dependent tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:991-999.
    PubMed     Abstract available


  321. NHUNG NV, Hoa NB, Anh NT, Anh LTN, et al
    Measuring catastrophic costs due to tuberculosis in Viet Nam.
    Int J Tuberc Lung Dis. 2018;22:983-990.
    PubMed     Abstract available


  322. DONALD PR, Diacon AH, Lange C, Demers AM, et al
    Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878-1940.
    Int J Tuberc Lung Dis. 2018;22:972-982.
    PubMed     Abstract available


  323. SCHWARTZMAN K
    You pay for what you get: the true cost of tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:969.
    PubMed    


    August 2018
  324. CHAN ED
    Thin body habitus is a risk factor for active pulmonary tuberculosis, but not for infection.
    Int J Tuberc Lung Dis. 2018;22:967-968.
    PubMed    


  325. ZELLWEGER JP
    Multidrug-resistant tuberculosis in Ukraine: what is hidden behind the numbers?
    Int J Tuberc Lung Dis. 2018;22:966-967.
    PubMed    


  326. YAN ZH, Yi L, Wei PJ, Jia HY, et al
    Evaluation of panels of Mycobacterium tuberculosis antigens for serodiagnosis of tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:959-965.
    PubMed     Abstract available


  327. DUPNIK KM, Bean JM, Lee MH, Jean Juste MA, et al
    Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum.
    Int J Tuberc Lung Dis. 2018;22:950-958.
    PubMed     Abstract available


  328. RAJOLI RKR, Podany AT, Moss DM, Swindells S, et al
    Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study.
    Int J Tuberc Lung Dis. 2018;22:937-944.
    PubMed     Abstract available


  329. ZHU H, Guo SC, Liu ZQ, Wang B, et al
    Therapeutic drug monitoring of cycloserine and linezolid during anti-tuberculosis treatment in Beijing, China.
    Int J Tuberc Lung Dis. 2018;22:931-936.
    PubMed     Abstract available


  330. COURT RG, Wiesner L, Chirehwa MT, Stewart A, et al
    Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:926-930.
    PubMed     Abstract available


  331. SCHNIPPEL K, Firnhaber C, Page-Shipp L, Sinanovic E, et al
    Impact of adverse drug reactions on the incremental cost-effectiveness of bedaquiline for drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:918-925.
    PubMed     Abstract available


  332. NAM VX, Nhung NV, Hoa NB, Thuy HTT, et al
    Economic burden of multidrug-resistant tuberculosis: a multicenter study across Vietnamese regions.
    Int J Tuberc Lung Dis. 2018;22:912-917.
    PubMed     Abstract available


  333. COLLINS D, Beyene D, Tedla Y, Mesfin H, et al
    Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia?
    Int J Tuberc Lung Dis. 2018;22:905-911.
    PubMed     Abstract available


  334. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    Improving rifampicin-resistant tuberculosis diagnosis using Xpert((R)) MTB/RIF: modelling interventions and costs.
    Int J Tuberc Lung Dis. 2018;22:890-898.
    PubMed     Abstract available


  335. CHAUDHARY A, Singh JP, Sehajpal PK, Sarin BC, et al
    P2X7 receptor polymorphisms and susceptibility to tuberculosis in a North Indian Punjabi population.
    Int J Tuberc Lung Dis. 2018;22:884-889.
    PubMed     Abstract available


  336. CHAWLA K, Kumar A, Shenoy VP, Chauhan DS, et al
    Strain diversity and relative transmission of Mycobacterium tuberculosis in south coastal Karnataka, India.
    Int J Tuberc Lung Dis. 2018;22:878-883.
    PubMed     Abstract available


  337. VAN DER HEIJDEN YF, Karim F, Chinappa T, Mufamadi G, et al
    Older age at first tuberculosis diagnosis is associated with tuberculosis recurrence in HIV-negative persons.
    Int J Tuberc Lung Dis. 2018;22:871-877.
    PubMed     Abstract available


  338. TURNER RD, Birring SS, Darmalingam M, Hooper RL, et al
    Daily cough frequency in tuberculosis and association with household infection.
    Int J Tuberc Lung Dis. 2018;22:863-870.
    PubMed     Abstract available


  339. HIRSCH-MOVERMAN Y, Mantell JE, Lebelo L, Wynn C, et al
    Tuberculosis preventive treatment preferences among care givers of children in Lesotho: a pilot study.
    Int J Tuberc Lung Dis. 2018;22:858-862.
    PubMed     Abstract available


  340. MALIK AA, Amanullah F, Codlin AJ, Siddiqui S, et al
    Improving childhood tuberculosis detection and treatment through facility-based screening in rural Pakistan.
    Int J Tuberc Lung Dis. 2018;22:851-857.
    PubMed     Abstract available


  341. SHETE PB, Boccia D, Dhavan P, Gebreselassie N, et al
    Defining a migrant-inclusive tuberculosis research agenda to end TB.
    Int J Tuberc Lung Dis. 2018;22:835-843.
    PubMed     Abstract available


  342. DOOLEY KE
    Long-acting injectables for tuberculosis prophylaxis and treatment: is now the time?
    Int J Tuberc Lung Dis. 2018;22:833-834.
    PubMed    


  343. CAMINERO JA, Scardigli A
    The economic burden of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:831-832.
    PubMed    


  344. SOMOSKOVI A, Gutierrez C
    Gaps in understanding factors influencing tuberculosis recurrence.
    Int J Tuberc Lung Dis. 2018;22:830.
    PubMed    


    July 2018
  345. HYDER MKA, Tripathy JP, Kaur J, Mandal PP, et al
    Tuberculosis-tobacco integration in the South-East Asia Region: policy analysis and implementation framework.
    Int J Tuberc Lung Dis. 2018;22:807-812.
    PubMed     Abstract available


  346. SINHA P, Moll AP, Brooks RP, Deng YH, et al
    Synergism between diabetes and human immunodeficiency virus in increasing the risk of tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:793-799.
    PubMed     Abstract available


  347. SCHININA V, Albarello F, Cristofaro M, Di Stefano F, et al
    Diagnostic imaging of hepatic tuberculosis: case series.
    Int J Tuberc Lung Dis. 2018;22:779-787.
    PubMed     Abstract available


  348. WALKER IF, Khan AM, Khan AM, Khan NM, et al
    Depression among multidrug-resistant tuberculosis patients in Punjab, Pakistan: a large cross-sectional study.
    Int J Tuberc Lung Dis. 2018;22:773-778.
    PubMed     Abstract available


  349. ODAYAR J, Rangaka MX, Zerbe A, Petro G, et al
    Burden of tuberculosis in HIV-positive pregnant women in Cape Town, South Africa.
    Int J Tuberc Lung Dis. 2018;22:760-765.
    PubMed     Abstract available


  350. GIMENEZ-DURAN J, Galmes-Truyols A, Gonzalez-Cortijo T, Portell-Arbona M, et al
    Capture-recapture and anti-tuberculosis drug prescriptions, Balearic Islands, Spain, 2010-2012.
    Int J Tuberc Lung Dis. 2018;22:754-759.
    PubMed     Abstract available


  351. REEVE BWP, McFall SM, Song R, Warren R, et al
    Commercial products to preserve specimens for tuberculosis diagnosis: a systematic review.
    Int J Tuberc Lung Dis. 2018;22:741-753.
    PubMed     Abstract available


  352. MULLER AM, Osorio CS, Silva DR, Sbruzzi G, et al
    Interventions to improve adherence to tuberculosis treatment: systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2018;22:731-740.
    PubMed     Abstract available


  353. FLOYD K, Glaziou P, Houben RMGJ, Sumner T, et al
    Global tuberculosis targets and milestones set for 2016-2035: definition and rationale.
    Int J Tuberc Lung Dis. 2018;22:723-730.
    PubMed     Abstract available


  354. WINTER JR, Adamu AL, Gupta RK, Stagg HR, et al
    Tuberculosis infection and disease in people living with HIV in countries with low tuberculosis incidence.
    Int J Tuberc Lung Dis. 2018;22:713-722.
    PubMed     Abstract available


  355. CASTRO KG, Colvin CE
    Updated global tuberculosis targets: a welcome ambition in need of attention to quality of care.
    Int J Tuberc Lung Dis. 2018;22:709.
    PubMed    


  356. GUPTE AN, Mave V, Meshram S, Lokhande R, et al
    Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India.
    Int J Tuberc Lung Dis. 2018;22:800-806.
    PubMed     Abstract available


  357. JEYASHREE K, Nayak P
    TB and tobacco integration: what is missing and what can we expect?
    Int J Tuberc Lung Dis. 2018;22:711.
    PubMed    


  358. BARRY PM, True L
    Using evidence to improve adherence and outcomes: personalized packages of patient support.
    Int J Tuberc Lung Dis. 2018;22:710.
    PubMed    


    June 2018
  359. YABLONSKII PK, Avetisyan AO, Vasilev IV, Kudriashov GG, et al
    Robot-assisted lobectomy for pulmonary tuberculosis in a case with immunosuppression after kidney transplantation.
    Int J Tuberc Lung Dis. 2018;22:704-705.
    PubMed    


  360. SHIVAKUMAR SVBY, Chandrasekaran P, Kumar AMV, Paradkar M, et al
    Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all?
    Int J Tuberc Lung Dis. 2018;22:686-694.
    PubMed     Abstract available


  361. CHIEN K, Seemangal J, Batt J, Vozoris NT, et al
    Abdominal tuberculosis: a descriptive case series of the experience in a Canadian tuberculosis clinic.
    Int J Tuberc Lung Dis. 2018;22:681-685.
    PubMed     Abstract available


  362. JACOBS MG, Pelissari DM, Pinto VL
    Factors associated with the drug-resistant tuberculosis incidence rate in Brazil.
    Int J Tuberc Lung Dis. 2018;22:675-680.
    PubMed     Abstract available


  363. LIU Y, Zheng Y, Chen J, Shi Y, et al
    Tuberculosis-associated mortality and its risk factors in a district of Shanghai, China: a retrospective cohort study.
    Int J Tuberc Lung Dis. 2018;22:655-660.
    PubMed     Abstract available


  364. MANSOUR O, Masini EO, Kim BJ, Kamene M, et al
    Impact of a national nutritional support programme on loss to follow-up after tuberculosis diagnosis in Kenya.
    Int J Tuberc Lung Dis. 2018;22:649-654.
    PubMed     Abstract available


  365. BOURGEOIS AC, Zulz T, Bruce MG, Stenz F, et al
    Tuberculosis in the Circumpolar Region, 2006-2012.
    Int J Tuberc Lung Dis. 2018;22:641-648.
    PubMed     Abstract available


  366. WANG KY, Lin YS, Sy CL, Huang WC, et al
    Hyperbaric oxygen therapy increases the risk of tuberculosis disease.
    Int J Tuberc Lung Dis. 2018;22:637-640.
    PubMed     Abstract available


  367. YANG ZH, Gorden T, Liu DP, Mukasa L, et al
    Increasing likelihood of advanced pulmonary tuberculosis at initial diagnosis in a low-incidence US state.
    Int J Tuberc Lung Dis. 2018;22:628-636.
    PubMed     Abstract available


  368. POPE V, Sacksteder KA, Hererra JC, Gilman RH, et al
    MPT64 patch test for the diagnosis of active pulmonary tuberculosis: a randomised controlled trial in Peru.
    Int J Tuberc Lung Dis. 2018;22:622-627.
    PubMed     Abstract available


  369. HORNE DJ, Jones BE, Kamada A, Fukushima K, et al
    Multicenter study of QuantiFERON((R))-TB Gold Plus in patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:617-621.
    PubMed     Abstract available


  370. WHITE RG, Charalambous S, Cardenas V, Hippner P, et al
    Evidence-informed policy making at country level: lessons learned from the South African Tuberculosis Think Tank.
    Int J Tuberc Lung Dis. 2018;22:606-613.
    PubMed     Abstract available


  371. DARA M, Zachariah R
    Hunger and tuberculosis: two sides of the same coin.
    Int J Tuberc Lung Dis. 2018;22:592.
    PubMed    


  372. MAGEE MJ, Gandhi NR, Kornfeld H
    A dual purpose for household contact investigations: preventing TB disease and improving diabetes outcomes.
    Int J Tuberc Lung Dis. 2018;22:594-595.
    PubMed    


  373. SOTGIU G, Loddenkemper R
    Insufficient pharmacological research on TB drugs: new insights on safety are needed.
    Int J Tuberc Lung Dis. 2018;22:593.
    PubMed    


  374. VAN LETH F, Sester M
    Testing for LTBI: more of the same or a step forward?
    Int J Tuberc Lung Dis. 2018;22:591.
    PubMed    


    May 2018
  375. KIM S, Seddon JA, Garcia-Prats AJ, Montepiedra G, et al
    Statistical considerations for pediatric multidrug-resistant tuberculosis efficacy trials.
    Int J Tuberc Lung Dis. 2018;22:34-39.
    PubMed     Abstract available


  376. GARCIA-PRATS AJ, Svensson EM, Weld ED, Schaaf HS, et al
    Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in children.
    Int J Tuberc Lung Dis. 2018;22:15-23.
    PubMed     Abstract available


  377. TUCKER EW, Dooley KE
    Preclinical tools for the evaluation of tuberculosis treatment regimens for children.
    Int J Tuberc Lung Dis. 2018;22:7-14.
    PubMed     Abstract available


  378. JENKINS HE, Yuen CM
    The burden of multidrug-resistant tuberculosis in children.
    Int J Tuberc Lung Dis. 2018;22:3-6.
    PubMed     Abstract available


  379. LALOR MK, Mohiyuddin T, Uddin T, Thomas HL, et al
    The challenge of estimating tuberculosis mortality accurately in England and Wales.
    Int J Tuberc Lung Dis. 2018;22:572-578.
    PubMed     Abstract available


  380. MELENDEZ J, Hogeweg L, Sanchez CI, Philipsen RHHM, et al
    Accuracy of an automated system for tuberculosis detection on chest radiographs in high-risk screening.
    Int J Tuberc Lung Dis. 2018;22:567-571.
    PubMed     Abstract available


  381. KUHLIN J, Smith C, Khaemraev A, Tigay Z, et al
    Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    Int J Tuberc Lung Dis. 2018;22:544-550.
    PubMed     Abstract available


  382. GGITA JM, Ojok C, Meyer AJ, Farr K, et al
    Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda.
    Int J Tuberc Lung Dis. 2018;22:530-536.
    PubMed     Abstract available


  383. MERID Y, Woldeamanuel Y, Abebe M, Datiko DG, et al
    High utility of active tuberculosis case finding in an Ethiopian prison.
    Int J Tuberc Lung Dis. 2018;22:524-529.
    PubMed     Abstract available


  384. KAWATSU L, Uchimura K, Izumi K, Ohkado A, et al
    Using surveillance data to simulate the impact of a hypothetical pre-entry tuberculosis screening programme in Japan.
    Int J Tuberc Lung Dis. 2018;22:510-517.
    PubMed     Abstract available


  385. SOHN H, Kim HY, Lee SH
    Cost-effectiveness of contact screening strategies for tuberculosis among high-school adolescents in South Korea.
    Int J Tuberc Lung Dis. 2018;22:496-503.
    PubMed     Abstract available


  386. BYAMUNGU LN, du Preez K, Walters E, Nachega JB, et al
    Timing of HIV diagnosis in children with tuberculosis managed at a referral hospital in Cape Town, South Africa.
    Int J Tuberc Lung Dis. 2018;22:488-495.
    PubMed     Abstract available


  387. GUPTA RK, Lipman M, Story A, Hayward A, et al
    Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era.
    Int J Tuberc Lung Dis. 2018;22:479-487.
    PubMed     Abstract available


  388. VELASQUEZ GE, Davies GR, Mitnick CD
    Making up the difference: ensuring the bioequivalence of fixed-dose combinations for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:473-474.
    PubMed    


  389. TWEED C, Nunn A
    Data in TB have to be both big and good.
    Int J Tuberc Lung Dis. 2018;22:476.
    PubMed    


  390. JOHNSON DF, Stout JE
    Corticosteroids for tuberculous pericarditis: can we learn from variability?
    Int J Tuberc Lung Dis. 2018;22:475.
    PubMed    


    April 2018
  391. HARRIES AD
    Impact of antiretroviral therapy on tuberculosis control.
    Int J Tuberc Lung Dis. 2018;22:466-467.
    PubMed    


  392. PAYEN MC, De Wit S
    In Reply: Synergy between amoxicillin and meropenem/clavulanate in drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:465-466.
    PubMed    


  393. MISHRA GP, Caminero JA
    Low-dose amoxicillin-clavulanate in drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:465.
    PubMed    


  394. CLICK ES, Ouma GS, DeGruy K, Murithi W, et al
    No evidence of Mycobacterium tuberculosis in breast milk of 18 women with confirmed TB disease in Kisumu, Kenya.
    Int J Tuberc Lung Dis. 2018;22:464-465.
    PubMed    


  395. MATHYS V, Roycroft E, Raftery P, Groenheit R, et al
    Time-and-motion tool for the assessment of working time in tuberculosis laboratories: a multicentre study.
    Int J Tuberc Lung Dis. 2018;22:444-451.
    PubMed     Abstract available


  396. BASHAM CA, Elias B, Fanning A, Cook C, et al
    Performance measurement of a Canadian provincial tuberculosis programme: Manitoba, 2008-2012.
    Int J Tuberc Lung Dis. 2018;22:437-443.
    PubMed     Abstract available


  397. MASKERY B, Posey DL, Coleman MS, Asis R, et al
    Economic analysis of CDC's culture- and smear-based tuberculosis instructions for Filipino immigrants.
    Int J Tuberc Lung Dis. 2018;22:429-436.
    PubMed     Abstract available


  398. ADEPOYIBI T, Lilis L, Greb H, Boyle D, et al
    Which attributes within target product profiles for tuberculosis diagnostics are the most important to focus on?
    Int J Tuberc Lung Dis. 2018;22:425-428.
    PubMed     Abstract available


  399. YADAV R, Saini A, Kaur P, Behera D, et al
    Diagnostic accuracy of GenoType((R)) MTBDRsl VER 2.0 in detecting second-line drug resistance to M. tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:419-424.
    PubMed     Abstract available


  400. COX V, Brigden G, Crespo RH, Lessem E, et al
    Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:407-412.
    PubMed     Abstract available


  401. HEYCKENDORF J, van Leth F, Avsar K, Glattki G, et al
    Treatment responses in multidrug-resistant tuberculosis in Germany.
    Int J Tuberc Lung Dis. 2018;22:399-406.
    PubMed     Abstract available


  402. SCHNIPPEL K, Firnhaber C, Berhanu R, Page-Shipp L, et al
    Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa.
    Int J Tuberc Lung Dis. 2018;22:393-398.
    PubMed     Abstract available


  403. HTET KKK, Soe KT, Kumar AMV, Saw S, et al
    Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?
    Int J Tuberc Lung Dis. 2018;22:385-392.
    PubMed     Abstract available


  404. ONYOH EF, Kuaban C, Lin HH
    Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon.
    Int J Tuberc Lung Dis. 2018;22:378-384.
    PubMed     Abstract available


  405. SHIN SS, Modongo C, Zetola NM, Wang Q, et al
    High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana.
    Int J Tuberc Lung Dis. 2018;22:366-370.
    PubMed     Abstract available


  406. REAVES EJ, Shah S, France AM, Morris SB, et al
    In Reply: Latent tuberculous infection testing among HIV-infected persons in clinical care.
    Int J Tuberc Lung Dis. 2018;22:468-469.
    PubMed    


  407. VAN BENTUM P, Swanink CMA, van Lochem EG, Claassen MAA, et al
    Prevalence of latent tuberculous infection among HIV-infected patients in a Dutch out-patient clinic.
    Int J Tuberc Lung Dis. 2018;22:467-468.
    PubMed    


  408. UPLEKAR M
    Using new TB tools: global rhetoric and ground reality.
    Int J Tuberc Lung Dis. 2018;22:357.
    PubMed    


  409. BAKER BJ
    ART and lifelong IPT for health care workers with HIV: a priority for infection control.
    Int J Tuberc Lung Dis. 2018;22:356.
    PubMed    


  410. TAN WC
    Low body mass index and latent tuberculous infection: current evidence?
    Int J Tuberc Lung Dis. 2018;22:355.
    PubMed    


    March 2018
  411. JACOBS C, Goussard P, Gie RP
    Mycobacterium tuberculosis, a cause of necrotising pneumonia in childhood: a case series.
    Int J Tuberc Lung Dis. 2018 Mar 22. doi: 10.5588/ijtld.17.0570.
    PubMed     Abstract available


  412. NAMIIRO S, Wobudeya E, Colebunders R, Worodria W, et al
    Molecular tests expedite the diagnosis of multidrug-resistant tuberculosis in childhood.
    Int J Tuberc Lung Dis. 2018;22:349-350.
    PubMed    


  413. BRUMWELL A, Noyes E, Kulkarni S, Lin V, et al
    A rapid review of treatment literacy materials for tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:336-341.
    PubMed     Abstract available


  414. BECKER AS, Bluthgen C, Phi van VD, Sekaggya-Wiltshire C, et al
    Detection of tuberculosis patterns in digital photographs of chest X-ray images using Deep Learning: feasibility study.
    Int J Tuberc Lung Dis. 2018;22:328-335.
    PubMed     Abstract available


  415. D'ATTILIO L, Diaz A, Fernandez RDV, Bongiovanni B, et al
    The neuro-endocrine-immune relationship in pulmonary and pleural tuberculosis: a better local profile in pleural fluid.
    Int J Tuberc Lung Dis. 2018;22:321-327.
    PubMed     Abstract available


  416. OLARU ID, Albert H, Zallet J, Werner UE, et al
    Impact of quality improvement in tuberculosis laboratories in low- and lower-middle-income countries: a systematic review.
    Int J Tuberc Lung Dis. 2018;22:309-320.
    PubMed     Abstract available


  417. BARK CM, Thiel BA, Ogwang S, Sekitoleko I, et al
    Sputum smear-positive, culture-negative state during anti-tuberculosis treatment in the MGIT liquid culture era.
    Int J Tuberc Lung Dis. 2018;22:306-308.
    PubMed     Abstract available


  418. FAN YM, Ding SP, Bao ZJ, Wu LM, et al
    Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China.
    Int J Tuberc Lung Dis. 2018;22:300-305.
    PubMed     Abstract available


  419. FRANCIS JR, Manchikanti P, Blyth CC, Denholm J, et al
    Multidrug-resistant tuberculosis in Australia, 1998-2012.
    Int J Tuberc Lung Dis. 2018;22:294-299.
    PubMed     Abstract available


  420. SMITH CM, Lessells R, Grant AD, Herbst K, et al
    Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015.
    Int J Tuberc Lung Dis. 2018;22:287-293.
    PubMed     Abstract available


  421. NGWIRA LG, Dowdy DW, Khundi M, Barnes GL, et al
    Delay in seeking care for tuberculosis symptoms among adults newly diagnosed with HIV in rural Malawi.
    Int J Tuberc Lung Dis. 2018;22:280-286.
    PubMed     Abstract available


  422. KWEZA PF, Van Schalkwyk C, Abraham N, Uys M, et al
    Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa.
    Int J Tuberc Lung Dis. 2018;22:264-272.
    PubMed     Abstract available


  423. FURTADO DA LUZ E, Braga JU
    Under-reporting of tuberculosis in Praia, Cape Verde, from 2006 to 2012.
    Int J Tuberc Lung Dis. 2018;22:258-263.
    PubMed     Abstract available


  424. DAVIDSON JA, Fulton N, Thomas HL, Lalor MK, et al
    Investigating a tuberculosis cluster among Filipino health care workers in a low-incidence country.
    Int J Tuberc Lung Dis. 2018;22:252-257.
    PubMed     Abstract available


  425. VAN DEUN A, Decroo T, Piubello A, de Jong BC, et al
    Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs.
    Int J Tuberc Lung Dis. 2018;22:239-245.
    PubMed     Abstract available


  426. ENGEL N
    Towards patient-centred care: analysing TB treatment literacy documents and adherence discourses.
    Int J Tuberc Lung Dis. 2018;22:238.
    PubMed    


  427. RIDZON R
    The tip of the iceberg.
    Int J Tuberc Lung Dis. 2018;22:237.
    PubMed    


    February 2018
  428. ALSHEVSKAYA AA, Kireev FD, Laushkina ZA, Lopatnikova JA, et al
    Enhanced expression of TNF-alpha type-1 receptors by immune cells in active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:212-220.
    PubMed     Abstract available


  429. BAIRD T, Donnan E, Coulter C, Simpson G, et al
    Multidrug-resistant tuberculosis in Queensland, Australia: an ongoing cross-border challenge.
    Int J Tuberc Lung Dis. 2018;22:206-211.
    PubMed     Abstract available


  430. PAVLENKO E, Barbova A, Hovhannesyan A, Tsenilova Z, et al
    Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.
    Int J Tuberc Lung Dis. 2018;22:197-205.
    PubMed     Abstract available


  431. ANTHONY-WILLIAMS MH, Farrugia BB, Montefort S
    Tuberculosis notification and treatment outcome among migrant boat arrivals in Malta, 2007-2011.
    Int J Tuberc Lung Dis. 2018;22:194-196.
    PubMed     Abstract available


  432. TAHSEEN S, Shahnawaz H, Riaz U, Khanzada FM, et al
    Systematic case finding for tuberculosis in HIV-infected people who inject drugs: experience from Pakistan.
    Int J Tuberc Lung Dis. 2018;22:187-193.
    PubMed     Abstract available


  433. JIAMSAKUL A, Lee MP, Nguyen KV, Merati TP, et al
    Socio-economic status and risk of tuberculosis: a case-control study of HIV-infected patients in Asia.
    Int J Tuberc Lung Dis. 2018;22:179-186.
    PubMed     Abstract available


  434. DE CASTRO DB, Sadahiro M, Pinto RC, de Albuquerque BC, et al
    Spatial distribution of tuberculosis in Manaus and its social determinants, 2008-2013.
    Int J Tuberc Lung Dis. 2018;22:171-178.
    PubMed     Abstract available


  435. ROSSER A, Marx FM, Pareek M
    Recurrent tuberculosis in the pre-elimination era.
    Int J Tuberc Lung Dis. 2018;22:139-150.
    PubMed     Abstract available


  436. ODONE A, Roberts B, Dara M, van den Boom M, et al
    People- and patient-centred care for tuberculosis: models of care for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:133-138.
    PubMed     Abstract available


  437. DUDNYK A, Chesov D, Lange C
    Mission impossible: the End TB strategy.
    Int J Tuberc Lung Dis. 2018;22:121-122.
    PubMed    


  438. MULLINS J, Lobato MN, Bemis K, Sosa L, et al
    Spatial clusters of latent tuberculous infection, Connecticut, 2010-2014.
    Int J Tuberc Lung Dis. 2018;22:165-170.
    PubMed     Abstract available


  439. SULIS G, Carvalho ACC, Capone S, Hamada Y, et al
    Policies and practices on the programmatic management of LTBI: a survey in the African Region.
    Int J Tuberc Lung Dis. 2018;22:158-164.
    PubMed     Abstract available


  440. SWINDELLS S, Siccardi M, Barrett SE, Olsen DB, et al
    Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges.
    Int J Tuberc Lung Dis. 2018;22:125-132.
    PubMed     Abstract available


    January 2018
  441. BYRNE AL, Marais BJ, Mitnick CD, Garden FL, et al
    Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru.
    Int J Tuberc Lung Dis. 2018;22:86-92.
    PubMed     Abstract available


  442. PINTO PFPS, Neto FC, de Almeida Ribeiro MCS
    Tuberculosis among South American immigrants in Sao Paulo municipality: an analysis in space and time.
    Int J Tuberc Lung Dis. 2018;22:80-85.
    PubMed     Abstract available


  443. WONG J, Lowenthal P, Flood J, Watt J, et al
    Increased tuberculosis risk among immigrants arriving in California with abnormal domestic chest radiographs.
    Int J Tuberc Lung Dis. 2018;22:73-79.
    PubMed     Abstract available


  444. SHIMAZAKI T, Taniguchi T, Saludar NRD, Gustilo LM, et al
    Bacterial co-infection and early mortality among pulmonary tuberculosis patients in Manila, The Philippines.
    Int J Tuberc Lung Dis. 2018;22:65-72.
    PubMed     Abstract available


  445. LEE B, Oh HJ, Chon BS
    Estimating the impact of a television campaign on tuberculosis knowledge and intention to test for TB in South Korea.
    Int J Tuberc Lung Dis. 2018;22:60-64.
    PubMed     Abstract available


  446. GUGLIELMETTI L, Veziris N, Aubry A, Brossier F, et al
    Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Int J Tuberc Lung Dis. 2018;22:54-59.
    PubMed     Abstract available


  447. EI PW, Aung WW, Nyunt WW, Swe TL, et al
    Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Int J Tuberc Lung Dis. 2018;22:47-53.
    PubMed     Abstract available


  448. LOVEDAY M, Sunkari B, Master I, Daftary A, et al
    Household context and psychosocial impact of childhood multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa.
    Int J Tuberc Lung Dis. 2018;22:40-46.
    PubMed     Abstract available


  449. PAYEN MC, Muylle I, Vandenberg O, Mathys V, et al
    Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.
    Int J Tuberc Lung Dis. 2018;22:34-39.
    PubMed     Abstract available


  450. COURT R, Wiesner L, Stewart A, de Vries N, et al
    Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:30-33.
    PubMed     Abstract available


  451. LEE PH, Fu H, Lee MR, Magee M, et al
    Tuberculosis and diabetes in low and moderate tuberculosis incidence countries.
    Int J Tuberc Lung Dis. 2018;22:7-16.
    PubMed     Abstract available


  452. JACKSON C, Cohen T, Rangaka MX, Abubakar I, et al
    Eliminating tuberculosis in low-burden countries.
    Int J Tuberc Lung Dis. 2018;22:3.
    PubMed    


  453. ALFFENAAR JWC, Peloquin CA, Migliori GB
    Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
    Int J Tuberc Lung Dis. 2018;22:2.
    PubMed    


    December 2017
  454. NANSUMBA M, Kumbakumba E, Orikiriza P, Bastard M, et al
    Treatment outcomes and tolerability of the revised WHO anti-tuberculosis drug dosages for children.
    Int J Tuberc Lung Dis. 2017 Dec 20. doi: 10.5588/ijtld.17.0535.
    PubMed     Abstract available


  455. ALLWOOD BW, van Zyl-Smit R
    Tuberculosis, chronic obstructive pulmonary disease and inhaled corticosteroids: a complex web.
    Int J Tuberc Lung Dis. 2017;21:1317-1318.
    PubMed    


  456. ZELLWEGER JP
    Depression and risk of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1314.
    PubMed    


  457. YU ZG, Wang BZ, Li J, Ding ZL, et al
    Association between interleukin-17 genetic polymorphisms and tuberculosis susceptibility: an updated meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1307-1313.
    PubMed     Abstract available


  458. SHU E, Sobieszczyk ME, Sal Y Rosas VG, Segura P, et al
    Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru.
    Int J Tuberc Lung Dis. 2017;21:1288-1293.
    PubMed     Abstract available


  459. MAVE V, Meshram S, Lokhande R, Kadam D, et al
    Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.
    Int J Tuberc Lung Dis. 2017;21:1280-1287.
    PubMed     Abstract available


  460. DELORY T, Ferrand H, Grall N, Casalino E, et al
    Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area.
    Int J Tuberc Lung Dis. 2017;21:1272-1279.
    PubMed     Abstract available


  461. DALE K, Tay E, Trauer JM, Trevan P, et al
    Gender differences in tuberculosis diagnosis, treatment and outcomes in Victoria, Australia, 2002-2015.
    Int J Tuberc Lung Dis. 2017;21:1264-1271.
    PubMed     Abstract available


  462. KUMWENDA M, Nyang'wa BT, Chikuse B, Biseck T, et al
    The second sputum sample complicates tuberculosis diagnosis for women: a qualitative study from Malawi.
    Int J Tuberc Lung Dis. 2017;21:1258-1263.
    PubMed     Abstract available


  463. NAGU T, Ray R, Munseri P, Moshiro C, et al
    Tuberculosis among the elderly in Tanzania: disease presentation and initial response to treatment.
    Int J Tuberc Lung Dis. 2017;21:1251-1257.
    PubMed     Abstract available


  464. MOH R, Badje A, N'takpe JB, Kouame GM, et al
    Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.
    Int J Tuberc Lung Dis. 2017;21:1237-1244.
    PubMed     Abstract available


  465. SURETTE MA, Beattie P, Nyirenda T, Olesen OF, et al
    Tackling tuberculosis in sub-Saharan Africa: EDCTP achievements and the road ahead.
    Int J Tuberc Lung Dis. 2017;21:1220-1229.
    PubMed     Abstract available


  466. HUANGFU P, Pearson F, Ugarte-Gil C, Critchley J, et al
    Diabetes and poor tuberculosis treatment outcomes: issues and implications in data interpretation and analysis.
    Int J Tuberc Lung Dis. 2017;21:1214-1219.
    PubMed     Abstract available


  467. COX V, Furin J
    World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied?
    Int J Tuberc Lung Dis. 2017;21:1211-1213.
    PubMed     Abstract available


    November 2017
  468. TREBUCQ A, Schwoebel V, Kashongwe Z, Bakayoko A, et al
    Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.
    Int J Tuberc Lung Dis. 2017 Nov 17. doi: 10.5588/ijtld.17.0498.
    PubMed     Abstract available


  469. MAARTENS G, Brill MJE, Pandie M, Svensson EM, et al
    Pharmacokinetic interaction between bedaquiline and clofazimine in patients with drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017 Nov 16. doi: 10.5588/ijtld.17.0615.
    PubMed     Abstract available


  470. BOYD R, Ford N, Padgen P, Cox H, et al
    Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1173-1180.
    PubMed     Abstract available


  471. MUCHENA G, Shambira G, Masuka N, Juru T, et al
    Determinants of multidrug resistance among previously treated tuberculosis patients in Zimbabwe, 2014.
    Int J Tuberc Lung Dis. 2017;21:1167-1172.
    PubMed     Abstract available


  472. GARCIA-GOEZ JF, Munera GA, Rojas V, Pacheco R, et al
    Tuberculosis in recipients of solid-organ transplants during 1995-2015 in Cali, Colombia.
    Int J Tuberc Lung Dis. 2017;21:1155-1159.
    PubMed     Abstract available


  473. KHAN PY, Crampin AC, Mzembe T, Koole O, et al
    Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis?
    Int J Tuberc Lung Dis. 2017;21:1147-1154.
    PubMed     Abstract available


  474. RIVERA VR, Jean-Juste MA, Gluck SC, Reeder HT, et al
    Diagnostic yield of active case finding for tuberculosis and HIV at the household level in slums in Haiti.
    Int J Tuberc Lung Dis. 2017;21:1140-1146.
    PubMed     Abstract available


  475. CHEN C, Yang CG, Gao X, Lu ZZ, et al
    Community-based active case finding for tuberculosis in rural western China: a cross-sectional study.
    Int J Tuberc Lung Dis. 2017;21:1134-1139.
    PubMed     Abstract available


  476. MULDER C, Mgode GF, Ellis H, Valverde E, et al
    Accuracy of giant African pouched rats for diagnosing tuberculosis: comparison with culture and Xpert(R) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:1127-1133.
    PubMed     Abstract available


  477. WELLS WA
    Onions and prevalence surveys: how to analyze and quantify tuberculosis case-finding gaps.
    Int J Tuberc Lung Dis. 2017;21:1101-1113.
    PubMed     Abstract available


  478. BAO J, Hafner R
    Conducting high-quality tuberculosis clinical trials in China: opportunities and challenges.
    Int J Tuberc Lung Dis. 2017;21:1094-1100.
    PubMed     Abstract available


  479. BORGDORFF MW, De Cock KM
    Provision of ART to individuals infected with HIV: impact on the epidemiology and control of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1091-1092.
    PubMed    


  480. MACINTYRE K, Bakker MI, Bergson S, Bhavaraju R, et al
    Defining the research agenda to measure and reduce tuberculosis stigmas.
    Int J Tuberc Lung Dis. 2017;21:87-96.
    PubMed     Abstract available


  481. SOMMERLAND N, Wouters E, Mitchell EMH, Ngicho M, et al
    Evidence-based interventions to reduce tuberculosis stigma: a systematic review.
    Int J Tuberc Lung Dis. 2017;21:81-86.
    PubMed     Abstract available


  482. SOMMERLAND N, Wouters E, Masquillier C, Engelbrecht M, et al
    Stigma as a barrier to the use of occupational health units for tuberculosis services in South Africa.
    Int J Tuberc Lung Dis. 2017;21:75-80.
    PubMed     Abstract available


  483. ZWERLING A, Dowdy D, von Delft A, Taylor H, et al
    Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment.
    Int J Tuberc Lung Dis. 2017;21:69-74.
    PubMed     Abstract available


  484. BOND V, Floyd S, Fenty J, Schaap A, et al
    Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR).
    Int J Tuberc Lung Dis. 2017;21:49-59.
    PubMed     Abstract available


  485. MILLER C, Huston J, Samu L, Mfinanga S, et al
    'It makes the patient's spirit weaker': tuberculosis stigma and gender interaction in Dar es Salaam, Tanzania.
    Int J Tuberc Lung Dis. 2017;21:42-48.
    PubMed     Abstract available


    October 2017
  486. THAKUR C, Verma S, Negi RS, Kumar V, et al
    Lophomonas blattarum co-infection in a patient with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1185-1187.
    PubMed    


  487. NABIROVA D, Schmid G, Yusupova R, Kantarbayeva M, et al
    Assessment of the quality of anti-tuberculosis medicines in Almaty, Kazakhstan, 2014.
    Int J Tuberc Lung Dis. 2017;21:1161-1168.
    PubMed     Abstract available


  488. REDDY S, Ntoyanto S, Sakadavan Y, Reddy T, et al
    Detecting Mycobacterium tuberculosis using the loop-mediated isothermal amplification test in South Africa.
    Int J Tuberc Lung Dis. 2017;21:1154-1160.
    PubMed     Abstract available


  489. YADAV R, Sharma N, Khaneja R, Agarwal P, et al
    Evaluation of the TB-LAMP assay for the rapid diagnosis of pulmonary tuberculosis in Northern India.
    Int J Tuberc Lung Dis. 2017;21:1150-1153.
    PubMed     Abstract available


  490. LIANG L, Shi R, Liu X, Yuan X, et al
    Interferon-gamma response to the treatment of active pulmonary and extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1145-1149.
    PubMed     Abstract available


  491. O'CONNOR DE, Frederix K, Saito S, Maama LB, et al
    Pulmonary tuberculosis diagnostic practices among people living with the human immunodeficiency virus in Lesotho.
    Int J Tuberc Lung Dis. 2017;21:1133-1138.
    PubMed     Abstract available


  492. SHARMA SK, Chaubey J, Singh BK, Sharma R, et al
    Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
    Int J Tuberc Lung Dis. 2017;21:1112-1117.
    PubMed     Abstract available


  493. SCHNIPPEL K, Firnhaber C, Ndjeka N, Conradie F, et al
    Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa.
    Int J Tuberc Lung Dis. 2017;21:1106-1111.
    PubMed     Abstract available


  494. MOHR E, Daniels J, Muller O, Furin J, et al
    Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert(R) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:1100-1105.
    PubMed     Abstract available


  495. JIANG Y, Cao B, Ohmagari N, Wu AH, et al
    Comprehensive understanding of health-seeking behaviour among pulmonary tuberculosis patients in China.
    Int J Tuberc Lung Dis. 2017;21:1094-1099.
    PubMed     Abstract available


  496. BROWN A, Ernst P, Cambule A, Morrow M, et al
    Applying the Care Group model to tuberculosis control: findings from a community-based project in Mozambique.
    Int J Tuberc Lung Dis. 2017;21:1086-1093.
    PubMed     Abstract available


  497. WILD V, Jaff D, Shah NS, Frick M, et al
    Tuberculosis, human rights and ethics considerations along the route of a highly vulnerable migrant from sub-Saharan Africa to Europe.
    Int J Tuberc Lung Dis. 2017;21:1075-1085.
    PubMed     Abstract available


  498. DENHOLM JT
    Strategic partnerships towards tuberculosis elimination.
    Int J Tuberc Lung Dis. 2017;21:1072.
    PubMed    


  499. VARAINE F
    Tuberculosis, human rights and ethics.
    Int J Tuberc Lung Dis. 2017;21:1071.
    PubMed    


    September 2017
  500. METCALFE J, Gerona R, Wen A, Bacchetti P, et al
    An LC-MS/MS-based method to analyze the anti-tuberculosis drug bedaquiline in hair.
    Int J Tuberc Lung Dis. 2017;21:1069-1070.
    PubMed    


  501. COLLINS D, Hafidz F, Mustikawati D
    The economic burden of tuberculosis in Indonesia.
    Int J Tuberc Lung Dis. 2017;21:1041-1048.
    PubMed     Abstract available


  502. MINH HV, Mai VQ, Nhung NV, Hoi LV, et al
    Costs of providing tuberculosis diagnosis and treatment services in Viet Nam.
    Int J Tuberc Lung Dis. 2017;21:1035-1040.
    PubMed     Abstract available


  503. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    High laboratory cost predicted per tuberculosis case diagnosed with increased case finding without a triage strategy.
    Int J Tuberc Lung Dis. 2017;21:1026-1034.
    PubMed     Abstract available


  504. NATHAVITHARANA RR, Daru P, Barrera AE, Mostofa Kamal SM, et al
    FAST implementation in Bangladesh: high frequency of unsuspected tuberculosis justifies challenges of scale-up.
    Int J Tuberc Lung Dis. 2017;21:1020-1025.
    PubMed     Abstract available


  505. YOON C, Chaisson LH, Patel SM, Allen IE, et al
    Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1013-1019.
    PubMed     Abstract available


  506. DATIKO DG, Yassin MA, Theobald SJ, Cuevas LE, et al
    A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:1002-1007.
    PubMed     Abstract available


  507. LIAO S, Cai C, Huo FM, Wu JN, et al
    Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre.
    Int J Tuberc Lung Dis. 2017;21:990-995.
    PubMed     Abstract available


  508. ZENNER D, Hafezi H, Potter J, Capone S, et al
    Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Int J Tuberc Lung Dis. 2017;21:965-976.
    PubMed     Abstract available


  509. PEDRAZZOLI D, Boccia D, Dodd PJ, Lonnroth K, et al
    Modelling the social and structural determinants of tuberculosis: opportunities and challenges.
    Int J Tuberc Lung Dis. 2017;21:957-964.
    PubMed     Abstract available


  510. CENTIS R, D'Ambrosio L, Migliori GB
    Understanding the multidrug-resistant tuberculosis epidemic in China.
    Int J Tuberc Lung Dis. 2017;21:955.
    PubMed    


    August 2017
  511. THOMAS B, Watson B, Senthil EK, Deepalakshmi A, et al
    Alcohol intervention strategy among tuberculosis patients: a pilot study from South India.
    Int J Tuberc Lung Dis. 2017;21:947-952.
    PubMed     Abstract available


  512. DESHMUKH PR, Mundra A, Dawale A
    Social capital and adverse treatment outcomes of tuberculosis: a case-control study.
    Int J Tuberc Lung Dis. 2017;21:941-946.
    PubMed     Abstract available


  513. RODRIGUEZ CA, Sasse S, Yuengling KA, Azzawi S, et al
    A systematic review of national policies for the management of persons exposed to tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:935-940.
    PubMed     Abstract available


  514. SOUSA M, Gomes M, Gaio AR, Duarte R, et al
    Nosocomial tuberculosis prevention in Portuguese hospitals: a cross-sectional evaluation.
    Int J Tuberc Lung Dis. 2017;21:930-934.
    PubMed     Abstract available


  515. MCDANIEL CJ, Chitnis AS, Barry PM, Shah N, et al
    Tuberculosis trends in California correctional facilities, 1993-2013.
    Int J Tuberc Lung Dis. 2017;21:922-929.
    PubMed     Abstract available


  516. RAJAN JV, Ferrazoli L, Waldman EA, Simonsen V, et al
    Diabetes increases the risk of recent-transmission tuberculosis in household contacts in Sao Paulo, Brazil.
    Int J Tuberc Lung Dis. 2017;21:916-921.
    PubMed     Abstract available


  517. MEHRA M, Kambili C, Potluri R, Rhines A, et al
    Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India.
    Int J Tuberc Lung Dis. 2017;21:902-909.
    PubMed     Abstract available


  518. CALDERON RI, Velasquez GE, Becerra MC, Zhang Z, et al
    Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.
    Int J Tuberc Lung Dis. 2017;21:894-901.
    PubMed     Abstract available


  519. MELENDEZ J, Philipsen RHHM, Chanda-Kapata P, Sunkutu V, et al
    Automatic versus human reading of chest X-rays in the Zambia National Tuberculosis Prevalence Survey.
    Int J Tuberc Lung Dis. 2017;21:880-886.
    PubMed     Abstract available


  520. BONNET M, Kyakwera C, Kyomugasho N, Atwine D, et al
    Prospective cohort study of the feasibility and yield of household child tuberculosis contact screening in Uganda.
    Int J Tuberc Lung Dis. 2017;21:862-868.
    PubMed     Abstract available


  521. SWEETLAND AC, Kritski A, Oquendo MA, Sublette ME, et al
    Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic.
    Int J Tuberc Lung Dis. 2017;21:852-861.
    PubMed     Abstract available


  522. KUNST H, Burman M, Arnesen TM, Fiebig L, et al
    Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.
    Int J Tuberc Lung Dis. 2017;21:840-851.
    PubMed     Abstract available


  523. SHAKOOR S, Hasan R
    Strategies for management of latent tuberculosis in endemic settings: building evidence.
    Int J Tuberc Lung Dis. 2017;21:836.
    PubMed    


  524. ZELLWEGER JP, Posey DL
    Migrant screening for tuberculosis and LTBI in Europe.
    Int J Tuberc Lung Dis. 2017;21:835.
    PubMed    


  525. WANG XH, Ma AG, Han XX, Chen L, et al
    Relationship between Toll-like receptor 4 and type-2 diabetes mellitus complicated by tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:910-915.
    PubMed     Abstract available


    July 2017
  526. HARRIES AD, Ade S, Hoa NB, Satyanarayana S, et al
    Use of inhaled corticosteroids for obstructive lung disease following anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2017;21:833-834.
    PubMed    


  527. MOHAMED EI, Mohamed MA, Moustafa MH, Abdel-Mageed SM, et al
    Qualitative analysis of biological tuberculosis samples by an electronic nose-based artificial neural network.
    Int J Tuberc Lung Dis. 2017;21:810-817.
    PubMed     Abstract available


  528. OH KH, Choi H, Kim EJ, Kim HJ, et al
    Depression and risk of tuberculosis: a nationwide population-based cohort study.
    Int J Tuberc Lung Dis. 2017;21:804-809.
    PubMed     Abstract available


  529. NERY JS, Rodrigues LC, Rasella D, Aquino R, et al
    Effect of Brazil's conditional cash transfer programme on tuberculosis incidence.
    Int J Tuberc Lung Dis. 2017;21:790-796.
    PubMed     Abstract available


  530. APOLINARIO D, Ribeiro AI, Krainski E, Sousa P, et al
    Tuberculosis inequalities and socio-economic deprivation in Portugal.
    Int J Tuberc Lung Dis. 2017;21:784-789.
    PubMed     Abstract available


  531. ZHU L, Yang YZ, Guan HY, Cheng SM, et al
    Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
    Int J Tuberc Lung Dis. 2017;21:759-765.
    PubMed     Abstract available


  532. THI SS, Parker DM, Swe LL, Pukrittayakamee S, et al
    Migration histories of multidrug-resistant tuberculosis patients from the Thailand-Myanmar border, 2012-2014.
    Int J Tuberc Lung Dis. 2017;21:753-758.
    PubMed     Abstract available


  533. SHETE PB, Nalugwa T, Farr K, Ojok C, et al
    Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.
    Int J Tuberc Lung Dis. 2017;21:746-752.
    PubMed     Abstract available


  534. DOUGLAS P, Posey DL, Zenner D, Robson J, et al
    Capacity strengthening through pre-migration tuberculosis screening programmes: IRHWG experiences.
    Int J Tuberc Lung Dis. 2017;21:737-745.
    PubMed     Abstract available


  535. DARA M, Sulis G, Centis R, D'Ambrosio L, et al
    Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences.
    Int J Tuberc Lung Dis. 2017;21:727-736.
    PubMed     Abstract available


  536. KUNST H
    Cross-border collaboration in tuberculosis prevention and care in Europe: can we do better?
    Int J Tuberc Lung Dis. 2017;21:717.
    PubMed    


    June 2017
  537. MAGEE MJ, Darchia L, Kipiani M, Chakhaia T, et al
    Smoking behavior and beliefs about the impact of smoking on anti-tuberculosis treatment among health care workers.
    Int J Tuberc Lung Dis. 2017 Jun 29. doi: 10.5588/ijtld.17.0023.
    PubMed     Abstract available


  538. DELGADO E, Monedero I, Bhavaraju R
    Resilience and extensively drug-resistant tuberculosis: the unlikely ally.
    Int J Tuberc Lung Dis. 2017;21:713-716.
    PubMed     Abstract available


  539. SIVAKUMAR P, Marples L, Breen R, Ahmed L, et al
    The diagnostic utility of pleural fluid adenosine deaminase for tuberculosis in a low prevalence area.
    Int J Tuberc Lung Dis. 2017;21:697-701.
    PubMed     Abstract available


  540. TELISINGHE L, Amofa-Sekyi M, Maluzi K, Kaluba-Milimo D, et al
    The sensitivity of the QuantiFERON(R)-TB Gold Plus assay in Zambian adults with active tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:690-696.
    PubMed     Abstract available


  541. BARR DA, Coussens AK, Irvine S, Ritchie ND, et al
    Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy.
    Int J Tuberc Lung Dis. 2017;21:677-683.
    PubMed     Abstract available


  542. VAN DER HEIJDEN YF, Karim F, Mufamadi G, Zako L, et al
    Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.
    Int J Tuberc Lung Dis. 2017;21:670-676.
    PubMed     Abstract available


  543. PATSCHE CB, Rudolf F, Mogensen SW, Sifna A, et al
    Low prevalence of malnourishment among household contacts of patients with tuberculosis in Guinea-Bissau.
    Int J Tuberc Lung Dis. 2017;21:664-669.
    PubMed     Abstract available


  544. STENNIS NL, Meissner JS, Bhavnani D, Kreiswirth B, et al
    Tuberculosis disease among Mexico-born individuals living in New York City, 2001-2014.
    Int J Tuberc Lung Dis. 2017;21:657-663.
    PubMed     Abstract available


  545. SNOW K, Hesseling AC, Naidoo P, Graham SM, et al
    Tuberculosis in adolescents and young adults: epidemiology and treatment outcomes in the Western Cape.
    Int J Tuberc Lung Dis. 2017;21:651-657.
    PubMed     Abstract available


  546. KALRA A
    Care seeking and treatment related delay among childhood tuberculosis patients in Delhi, India.
    Int J Tuberc Lung Dis. 2017;21:645-650.
    PubMed     Abstract available


  547. ZIEMELE B, Ranka R, Ozere I
    Pediatric and adolescent tuberculosis in Latvia, 2011-2014: case detection, diagnosis and treatment.
    Int J Tuberc Lung Dis. 2017;21:637-645.
    PubMed     Abstract available


  548. LONNROTH K, Mor Z, Erkens C, Bruchfeld J, et al
    Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.
    Int J Tuberc Lung Dis. 2017;21:624-637.
    PubMed     Abstract available


  549. DHAVAN P, Dias HM, Creswell J, Weil D, et al
    An overview of tuberculosis and migration.
    Int J Tuberc Lung Dis. 2017;21:610-623.
    PubMed     Abstract available


  550. WALKER IF, Baral SC, Wei X, Huque R, et al
    Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders.
    Int J Tuberc Lung Dis. 2017;21:603-609.
    PubMed     Abstract available


  551. SEDDON JA, Gie RP
    If you look, you will find: time to challenge the childhood tuberculosis paradigm.
    Int J Tuberc Lung Dis. 2017;21:602.
    PubMed    


  552. RAVIGLIONE MC, Mosca D
    Migrant health and tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:599-600.
    PubMed    


  553. OWUSU-EDUSEI K, Stockbridge EL, Winston CA, Kolasa M, et al
    Tuberculin skin test and interferon-gamma release assay use among privately insured persons in the United States.
    Int J Tuberc Lung Dis. 2017;21:684-689.
    PubMed     Abstract available


    May 2017
  554. J-Y FENG JY, Jarlsberg LG, Salcedo K, Rose J, et al
    Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017 May 16. doi: 10.5588/ijtld.16.0510.
    PubMed     Abstract available


  555. ARSCOTT-MILLS T, Masole L, Ncube R, Steenhoff AP, et al
    Survey of health care worker knowledge about childhood tuberculosis in high-burden centers in Botswana.
    Int J Tuberc Lung Dis. 2017;21:586-591.
    PubMed     Abstract available


  556. SCOTT C, Mangan J, Tillova Z, Jensen PA, et al
    Evaluation of the Tuberculosis Infection Control Training Center, Tajikistan, 2014-2015.
    Int J Tuberc Lung Dis. 2017;21:579-585.
    PubMed     Abstract available


  557. ADAMS LV, Basu D, Grande SW, Craig SR, et al
    Barriers to tuberculosis care delivery among miners and their families in South Africa: an ethnographic study.
    Int J Tuberc Lung Dis. 2017;21:571-578.
    PubMed     Abstract available


  558. UKWAJA KN, Alobu I, Gidado M, Onazi O, et al
    Economic support intervention improves tuberculosis treatment outcomes in rural Nigeria.
    Int J Tuberc Lung Dis. 2017;21:564-570.
    PubMed     Abstract available


  559. LOVEDAY M, Ramjee A, Osburn G, Master I, et al
    Drug-resistant tuberculosis in patients with minimal symptoms: favourable outcomes in the absence of treatment.
    Int J Tuberc Lung Dis. 2017;21:556-563.
    PubMed     Abstract available


  560. DALE KD, Globan M, Tay EL, Trauer JM, et al
    Recurrence of tuberculosis in a low-incidence setting without directly observed treatment: Victoria, Australia, 2002-2014.
    Int J Tuberc Lung Dis. 2017;21:550-555.
    PubMed     Abstract available


  561. MAHARAJ B, Gengiah TN, Yende-Zuma N, Gengiah S, et al
    Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.
    Int J Tuberc Lung Dis. 2017;21:537-543.
    PubMed     Abstract available


  562. SSENGOOBA W, Lukoye D, Meehan CJ, Kateete DP, et al
    Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.
    Int J Tuberc Lung Dis. 2017;21:531-536.
    PubMed     Abstract available


  563. SATAKE Y, Nakamura Y, Kono M, Hozumi H, et al
    Type-1 polarised dendritic cells are a potent immunogen against Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:523-530.
    PubMed     Abstract available


  564. RONALD LA, Ling DI, FitzGerald JM, Schwartzman K, et al
    Validated methods for identifying tuberculosis patients in health administrative databases: systematic review.
    Int J Tuberc Lung Dis. 2017;21:517-522.
    PubMed     Abstract available


  565. FENG JY, Jarlsberg LG, Rose J, Grinsdale JA, et al
    Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.
    Int J Tuberc Lung Dis. 2017;21:509-516.
    PubMed     Abstract available


  566. HO J, Jelfs P, Nguyen PT, Sintchenko V, et al
    Pooling sputum samples to improve the feasibility of Xpert(R) MTB/RIF in systematic screening for tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:503-508.
    PubMed     Abstract available


  567. VAN AART C, Boshuizen H, Dekkers A, Korthals Altes H, et al
    Time lag between immigration and tuberculosis rates in immigrants in the Netherlands: a time-series analysis.
    Int J Tuberc Lung Dis. 2017;21:486-492.
    PubMed     Abstract available


  568. POSEY DL, Marano N, Cetron MS
    Cross-border solutions needed to address tuberculosis in migrating populations.
    Int J Tuberc Lung Dis. 2017;21:485-486.
    PubMed    


  569. YATES TA, Atkinson SH
    Ironing out sex differences in tuberculosis prevalence.
    Int J Tuberc Lung Dis. 2017;21:483-484.
    PubMed    


  570. WORTHAM JM, Goggin M, Mora C, Vandehey L, et al
    Acute kidney injury during treatment for latent tuberculous infection with rifampin.
    Int J Tuberc Lung Dis. 2017;21:596-597.
    PubMed     Abstract available


  571. LANGE B, Khan P, Kalmambetova G, Al-Darraji HA, et al
    Diagnostic accuracy of the Xpert((R)) MTB/RIF cycle threshold level to predict smear positivity: a meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:493-502.
    PubMed     Abstract available


    April 2017
  572. JAIN A, Singh PK, Singh U, Kumar V, et al
    Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Int J Tuberc Lung Dis. 2017;21:478-480.
    PubMed    


  573. CHONG SG, Herron M, Dorman A, Little M, et al
    Renal amyloidosis complicating multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:476-477.
    PubMed    


  574. BLOK L, Bakker MI, Straetemans M, Gerstel L, et al
    Should active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:475.
    PubMed    


  575. WEBER SF, Belard S, Rai S, Reddy R, et al
    Immune thrombocytopenia secondary to tuberculosis: a case and review of literature.
    Int J Tuberc Lung Dis. 2017;21:466-470.
    PubMed     Abstract available


  576. VALENCIA S, Respeito D, Blanco S, Ribeiro RM, et al
    Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhica.
    Int J Tuberc Lung Dis. 2017;21:446-451.
    PubMed     Abstract available


  577. ADLER H, Archary M, Mahabeer P, LaRussa P, et al
    Tuberculosis in HIV-infected South African children with complicated severe acute malnutrition.
    Int J Tuberc Lung Dis. 2017;21:438-445.
    PubMed     Abstract available


  578. CARTER KL, Gabrellas AD, Shah S, Garland JM, et al
    Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist.
    Int J Tuberc Lung Dis. 2017;21:432-437.
    PubMed     Abstract available


  579. ARMENTA RF, Collins KM, Strathdee SA, Bulterys MA, et al
    Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California.
    Int J Tuberc Lung Dis. 2017;21:425-431.
    PubMed     Abstract available


  580. SHAIKH N, Gupte A, Dharmshale S, Pokkali S, et al
    Novel interferon-gamma assays for diagnosing tuberculosis in young children in India.
    Int J Tuberc Lung Dis. 2017;21:412-419.
    PubMed     Abstract available


  581. VAN WYK SS, Lin HH, Claassens MM
    A systematic review of prediction models for prevalent pulmonary tuberculosis in adults.
    Int J Tuberc Lung Dis. 2017;21:405-411.
    PubMed     Abstract available


  582. OWUSU-EDUSEI K, Marks SM, Miramontes R, Stockbridge EL, et al
    Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.
    Int J Tuberc Lung Dis. 2017;21:398-404.
    PubMed     Abstract available


  583. RUPERT S, Vassall A, Raizada N, Khaparde SD, et al
    Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India.
    Int J Tuberc Lung Dis. 2017;21:375-380.
    PubMed     Abstract available


  584. PANDEY S, Chadha VK, Laxminarayan R, Arinaminpathy N, et al
    Estimating tuberculosis incidence from primary survey data: a mathematical modeling approach.
    Int J Tuberc Lung Dis. 2017;21:366-374.
    PubMed     Abstract available


  585. DODD PJ
    Tracking tuberculosis incidence: time to tool up.
    Int J Tuberc Lung Dis. 2017;21:363.
    PubMed    


  586. ADINARAYANAN S, Culp RK, Subramani R, Abbas KM, et al
    Role of bacille Calmette-Guerin in preventing tuberculous infection.
    Int J Tuberc Lung Dis. 2017;21:420-424.
    PubMed     Abstract available


  587. ACUNA-VILLAORDUNA C, Orikiriza P, Nyehangane D, White LF, et al
    Effect of previous treatment and sputum quality on diagnostic accuracy of Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:389-397.
    PubMed     Abstract available


  588. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    Operational modelling: the mechanisms influencing TB diagnostic yield in an Xpert((R)) MTB/RIF-based algorithm.
    Int J Tuberc Lung Dis. 2017;21:381-388.
    PubMed     Abstract available


    March 2017
  589. ZHANG ZX, Sng LH, Yong Y, Lin LM, et al
    Delays in diagnosis and treatment of pulmonary tuberculosis in AFB smear-negative patients with pneumonia.
    Int J Tuberc Lung Dis. 2017 Mar 16. doi: 10.5588/ijtld.16.0667.
    PubMed     Abstract available


  590. MASJEDI MR, Hosseini M, Aryanpur M, Mortaz E, et al
    The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:351-356.
    PubMed     Abstract available


  591. BOONYAGARS L, Hirunwiwatkul P, Hurst CP
    CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Int J Tuberc Lung Dis. 2017;21:338-344.
    PubMed     Abstract available


  592. DIAS M, Gaio R, Sousa P, Abranches M, et al
    Tuberculosis among the homeless: should we change the strategy?
    Int J Tuberc Lung Dis. 2017;21:327-332.
    PubMed     Abstract available


  593. O'HARA LM, Yassi A, Bryce EA, van Rensburg AJ, et al
    Infection control and tuberculosis in health care workers: an assessment of 28 hospitals in South Africa.
    Int J Tuberc Lung Dis. 2017;21:320-326.
    PubMed     Abstract available


  594. HUERGA H, Bastard M, Kamene M, Wanjala S, et al
    Outcomes from the first multidrug-resistant tuberculosis programme in Kenya.
    Int J Tuberc Lung Dis. 2017;21:314-319.
    PubMed     Abstract available


  595. JAVAID A, Hasan R, Zafar A, Chaudry MA, et al
    Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Int J Tuberc Lung Dis. 2017;21:303-308.
    PubMed     Abstract available


  596. FOX GJ, Anh NT, Nhung NV, Loi NT, et al
    Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:297-302.
    PubMed     Abstract available


  597. KAMAKIA R, Kiazyk S, Waruk J, Meyers A, et al
    Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:278-285.
    PubMed     Abstract available


  598. NAUSCH N, Lundtoft C, Schulz G, Henckel H, et al
    Multiple cytokines for the detection of Mycobacterium tuberculosis infection in children with tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:270-277.
    PubMed     Abstract available


  599. DONNAN EJ, Coulter C, Simpson G, Clark J, et al
    Paediatric tuberculosis in Queensland, Australia: overrepresentation of cross-border and Indigenous children.
    Int J Tuberc Lung Dis. 2017;21:263-269.
    PubMed     Abstract available


  600. CRANMER LM, Langat A, Ronen K, McGrath CJ, et al
    Integrating tuberculosis screening in Kenyan Prevention of Mother-To-Child Transmission programs.
    Int J Tuberc Lung Dis. 2017;21:256-262.
    PubMed     Abstract available


  601. REICHMAN LB
    The tuberculosis taboo.
    Int J Tuberc Lung Dis. 2017;21:251-255.
    PubMed     Abstract available


  602. KURBANIYAZOVA G, Joncevska M, Kalon S, Kalmambetova G, et al
    Results of Xpert((R)) MTB/RIF implementation in Kyrgyzstan.
    Int J Tuberc Lung Dis. 2017;21:333-337.
    PubMed     Abstract available


  603. ANASTASAKOS V, Skouras V, Moschos C, Tsikrika S, et al
    Patterns of drug resistance among patients with tuberculous pleural effusion in Greece.
    Int J Tuberc Lung Dis. 2017;21:309-313.
    PubMed     Abstract available


  604. MORO RN, Sterling TR, Saukkonen J, Vernon A, et al
    Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.
    Int J Tuberc Lung Dis. 2017;21:286-296.
    PubMed     Abstract available


    February 2017
  605. PRIYADARSHINI P, Tiwari K, Das A, Kumar D, et al
    Evaluation of highly conserved hsp65-specific nested PCR primers for diagnosing Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:214-217.
    PubMed     Abstract available


  606. MCEBULA V, Crowther NJ, Nagel SE, George JA, et al
    Diabetes and abnormal glucose tolerance in subjects with tuberculosis in a South African urban center.
    Int J Tuberc Lung Dis. 2017;21:208-213.
    PubMed     Abstract available


  607. BRYLA M, Dziankowska-Zaborszczyk E, Maniecka-Bryla I
    Standard expected years of life lost due to tuberculosis in Poland.
    Int J Tuberc Lung Dis. 2017;21:202-207.
    PubMed     Abstract available


  608. CLAASSENS MM, Dunbar R, Yang B, Lombard CJ, et al
    Scanty smears associated with initial loss to follow-up in South African tuberculosis patients.
    Int J Tuberc Lung Dis. 2017;21:196-201.
    PubMed     Abstract available


  609. IZUMI K, Ohkado A, Uchimura K, Kawatsu L, et al
    Evaluation of tuberculosis contact investigations in Japan.
    Int J Tuberc Lung Dis. 2017;21:188-195.
    PubMed     Abstract available


  610. HTET KK, Liabsuetrakul T, Thein S
    Cost-effectiveness of a new strategy to detect pulmonary tuberculosis in household contacts in Myanmar.
    Int J Tuberc Lung Dis. 2017;21:181-187.
    PubMed     Abstract available


  611. GUGLIELMETTI L, Hewison C, Avaliani Z, Hughes J, et al
    Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.
    Int J Tuberc Lung Dis. 2017;21:167-174.
    PubMed     Abstract available


  612. CHIPINDURO M, Mateveke K, Makamure B, Ferrand RA, et al
    Stool Xpert(R) MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis at primary clinics in Zimbabwe.
    Int J Tuberc Lung Dis. 2017;21:161-166.
    PubMed     Abstract available


  613. CHIANG SS, Roche S, Contreras C, Del Castillo H, et al
    Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.
    Int J Tuberc Lung Dis. 2017;21:154-160.
    PubMed     Abstract available


  614. LOPEZ C, Bertram-Farough A, Heywood D, Dawson L, et al
    Knowing about you: eliciting dimensions of personhood within tuberculosis care.
    Int J Tuberc Lung Dis. 2017;21:149-153.
    PubMed     Abstract available


  615. PARENT SN, Ehrlich R, Baxter V, Kannemeyer N, et al
    Participatory theatre and tuberculosis: a feasibility study with South African health care workers.
    Int J Tuberc Lung Dis. 2017;21:140-148.
    PubMed     Abstract available


  616. STAGG HR, Lipman MC, McHugh TD, Jenkins HE, et al
    Isoniazid-resistant tuberculosis: a cause for concern?
    Int J Tuberc Lung Dis. 2017;21:129-139.
    PubMed     Abstract available


  617. USDIN M, Dedicoat M, Gajraj R, Harrison P, et al
    Latent tuberculous screening of recent migrants attending language classes: a cohort study and cost analysis.
    Int J Tuberc Lung Dis. 2017;21:175-180.
    PubMed     Abstract available


    January 2017
  618. RIEDER HL, Van Deun A
    Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:123-124.
    PubMed    


  619. REVES R, Benjamin R
    The cost of the failure to eliminate tuberculosis in the United States.
    Int J Tuberc Lung Dis. 2017;21:120.
    PubMed    


  620. KUMAR NP, Velayutham B, Nair D, Babu S, et al
    Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:93-99.
    PubMed     Abstract available


  621. DAVIS A, Terlikbayeva A, Aifah A, Hermosilla S, et al
    Risks for tuberculosis in Kazakhstan: implications for prevention.
    Int J Tuberc Lung Dis. 2017;21:86-92.
    PubMed     Abstract available


  622. SHAWENO D, Shaweno T, Trauer JM, Denholm JT, et al
    Heterogeneity of distribution of tuberculosis in Sheka Zone, Ethiopia: drivers and temporal trends.
    Int J Tuberc Lung Dis. 2017;21:79-85.
    PubMed     Abstract available


  623. KOURA KG, Trebucq A, Schwoebel V
    Do active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:73-78.
    PubMed     Abstract available


  624. RUDOLF F, Wagner AJ, Back FM, Gomes VF, et al
    Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR.
    Int J Tuberc Lung Dis. 2017;21:67-72.
    PubMed     Abstract available


  625. RAGONNET R, Trauer JM, McBryde ES, Houben RM, et al
    Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.
    Int J Tuberc Lung Dis. 2017;21:60-66.
    PubMed     Abstract available


  626. CHABALA C, Chongwe G, Jumbe-Marsden E, Somwe SW, et al
    Missed opportunities for screening child contacts of smear-positive tuberculosis in Zambia, a high-prevalence setting.
    Int J Tuberc Lung Dis. 2017;21:53-59.
    PubMed     Abstract available


  627. EGERE U, Togun T, Sillah A, Mendy F, et al
    Identifying children with tuberculosis among household contacts in The Gambia.
    Int J Tuberc Lung Dis. 2017;21:46-52.
    PubMed     Abstract available


  628. ZELDOW B, Kim S, McSherry G, Cotton MF, et al
    Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.
    Int J Tuberc Lung Dis. 2017;21:38-45.
    PubMed     Abstract available


  629. JERENE D, Abebe W, Taye K, Suarez PG, et al
    Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:32-37.
    PubMed     Abstract available


  630. TUPASI T, Garfin AM, Mangan JM, Orillaza-Chi R, et al
    Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.
    Int J Tuberc Lung Dis. 2017;21:23-31.
    PubMed     Abstract available


  631. WELDEGEBREAL S, Mebrahtu T
    Anti-tuberculosis drug resistance in Ethiopia: systematic review.
    Int J Tuberc Lung Dis. 2017;21:18-22.
    PubMed     Abstract available


  632. BANU S, Rahman MT, Ahmed S, Khatun R, et al
    Multidrug-resistant tuberculosis in Bangladesh: results from a sentinel surveillance system.
    Int J Tuberc Lung Dis. 2017;21:12-17.
    PubMed     Abstract available


  633. NOURZAD S, Jenkins HE, Milstein M, Mitnick CD, et al
    Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:6-11.
    PubMed     Abstract available


  634. FURIN J, Diacon AH, Andries K
    Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Int J Tuberc Lung Dis. 2017;21:4-5.
    PubMed    


    December 2016
  635. STURKENBOOM MG, Bolhuis MS, Akkerman OW, de Lange WC, et al
    Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurements.
    Int J Tuberc Lung Dis. 2016;20:1695-1696.
    PubMed    


  636. VELAYUTHAM B, Nair D, Kannan T, Padmapriyadarsini C, et al
    Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1671-1676.
    PubMed     Abstract available


  637. SINGANAYAGAM A, Manalan K, Connell DW, Chalmers JD, et al
    Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1653-1660.
    PubMed     Abstract available


  638. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Abstract available


  639. CONNERS E, Garfein RS, Rodwell TC, Udwadia ZF, et al
    Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1633-1638.
    PubMed     Abstract available


  640. ZELNICK JR, O'Donnell MR, Ahuja SD, Chua A, et al
    Health care provider perspectives on tuberculosis care for foreign-born populations in New York City.
    Int J Tuberc Lung Dis. 2016;20:1625-1632.
    PubMed     Abstract available


  641. BRIGHT-THOMAS RJ, Gondker AR, Morris J, Ormerod LP, et al
    Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
    Int J Tuberc Lung Dis. 2016;20:1621-1624.
    PubMed     Abstract available


  642. RENDELL NL, Batjargal N, Jadambaa N, Dobler CC, et al
    Risk of tuberculosis during pregnancy in Mongolia, a high incidence setting with low HIV prevalence.
    Int J Tuberc Lung Dis. 2016;20:1615-1620.
    PubMed     Abstract available


  643. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Abstract available


  644. SIROKA A, Law I, Macinko J, Floyd K, et al
    The effect of household poverty on tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1603-1608.
    PubMed     Abstract available


  645. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 20012011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Abstract available


  646. JENSEN SG, Lillebaek T, Wilcke T, Pedersen MK, et al
    Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark.
    Int J Tuberc Lung Dis. 2016;20:1580-1587.
    PubMed     Abstract available


  647. CASTRO KG
    Detection and treatment of persons with latent tuberculosis infection: first eliminate the policy-to-practice gap.
    Int J Tuberc Lung Dis. 2016;20:1565.
    PubMed    


  648. TALAVERA-PAULIN M, Garcia-Morales L, Ruiz-Sanchez BP, Caamal-Ley AD, et al
    Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins.
    Int J Tuberc Lung Dis. 2016;20:1681-1688.
    PubMed     Abstract available


  649. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON(R)-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Abstract available


  650. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Abstract available


  651. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 2001-2011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Abstract available


  652. BRUGUERAS S, Orcau A, Millet JP, Espinosa L, et al
    Tuberculosis clinical units improve contact tracing.
    Int J Tuberc Lung Dis. 2016;20:1572-1579.
    PubMed     Abstract available


  653. O'DONNELL MR, Padayatchi N, Metcalfe JZ
    Elucidating the role of clofazimine for the treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:52-57.
    PubMed     Abstract available


  654. NUERMBERGER E
    Evolving strategies for dose optimization of linezolid for treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:48-51.
    PubMed     Abstract available


  655. STERLING TR
    Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:42-47.
    PubMed     Abstract available


  656. MURRAY S, Mendel C, Spigelman M
    TB Alliance regimen development for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:38-41.
    PubMed     Abstract available


  657. GUPTA R, Wells CD, Hittel N, Hafkin J, et al
    Delamanid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:33-37.
    PubMed     Abstract available


  658. MILSTEIN M, Brzezinski A, Varaine F, Mitnick CD, et al
    (Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:18-23.
    PubMed     Abstract available


    November 2016
  659. DHOLAKIA Y, Mistry N
    Active tuberculosis case finding in a migrant slum community, Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1562.
    PubMed    


  660. LEVIN A, Sklyuev S, Felker I, Tceymach E, et al
    Endobronchial valve treatment of destructive multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1539-1545.
    PubMed     Abstract available


  661. PINA RZ, Caleffi-Ferracioli KR, Campanerut-Sa PA, Ghiraldi-Lopez LD, et al
    Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
    Int J Tuberc Lung Dis. 2016;20:1535-1538.
    PubMed     Abstract available


  662. ALIPANAH N, Cattamanchi A, Menzies R, Hopewell PC, et al
    Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:1522-1528.
    PubMed     Abstract available


  663. KIM CH, Lim JK, Lee DH, Yoo SS, et al
    Outcomes of standard and tailored anti-tuberculosis regimens in patients with tuberculous pleural effusion.
    Int J Tuberc Lung Dis. 2016;20:1516-1521.
    PubMed     Abstract available


  664. IGLECIAS LM, Puga MA, Pompilio MA, Teles SA, et al
    Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil.
    Int J Tuberc Lung Dis. 2016;20:1509-1515.
    PubMed     Abstract available


  665. IZUMI K, Kawatsu L, Ohkado A, Uchimura K, et al
    Evaluating the impact of health resource reconstruction on improving spatial accessibility of tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:1501-1508.
    PubMed     Abstract available


  666. LOPEZ AL, Aldaba JG, Ama CG, Sylim PG, et al
    Surveillance for tuberculosis in a rural community in The Philippines.
    Int J Tuberc Lung Dis. 2016;20:1495-1500.
    PubMed     Abstract available


  667. NOESKE J, Nana Yakam A, Abena Foe JL
    Epidemiology of tuberculosis in Cameroon as mirrored in notification data, 2006-2014.
    Int J Tuberc Lung Dis. 2016;20:1489-1494.
    PubMed     Abstract available


  668. DAFTARY A, Padayatchi N
    Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.
    Int J Tuberc Lung Dis. 2016;20:1483-1488.
    PubMed     Abstract available


  669. MIBEI DJ, Kiarie JW, Wairia A, Kamene M, et al
    Treatment outcomes of drug-resistant tuberculosis patients in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1477-1482.
    PubMed     Abstract available


  670. GARCIA-PRATS AJ, du Plessis L, Draper HR, Burger A, et al
    Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:1469-1476.
    PubMed     Abstract available


  671. CHAYA S, Dangor Z, Solomon F, Nzenze SA, et al
    Incidence of tuberculosis meningitis in a high HIV prevalence setting: time-series analysis from 2006 to 2011.
    Int J Tuberc Lung Dis. 2016;20:1457-1462.
    PubMed     Abstract available


  672. TURKOVA A, Chappell E, Chalermpantmetagul S, Negra MD, et al
    Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study.
    Int J Tuberc Lung Dis. 2016;20:1448-1456.
    PubMed     Abstract available


  673. JAGANATH D, Lamichhane G, Shah M
    Carbapenems against Mycobacterium tuberculosis: a review of the evidence.
    Int J Tuberc Lung Dis. 2016;20:1436-1447.
    PubMed     Abstract available


  674. UPLEKAR M
    Public-private mix for tuberculosis care and prevention. What progress? What prospects?
    Int J Tuberc Lung Dis. 2016;20:1424-1429.
    PubMed     Abstract available


    October 2016
  675. NUNN A, Tweed C
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:1418-1419.
    PubMed    


  676. KARAKAS A, Turhan V, Esquinas AM
    Reasons for high mortality rates in patients with pulmonary tuberculosis needing mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:1416-1417.
    PubMed    


  677. FRIEDEN TR
    Positive bacteriological results among contacts of patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1416.
    PubMed    


  678. NAIDOO P, Dunbar R, du Toit E, van Niekerk M, et al
    Comparing laboratory costs of smear/culture and Xpert(R) MTB/RIF-based tuberculosis diagnostic algorithms.
    Int J Tuberc Lung Dis. 2016;20:1377-1385.
    PubMed     Abstract available


  679. ZHAO Q, Xiao X, Lu W, Qiu LX, et al
    Screening diabetes in tuberculosis patients in eastern rural China: a community-based cross-sectional study.
    Int J Tuberc Lung Dis. 2016;20:1370-1376.
    PubMed     Abstract available


  680. WATTANAPOKAYAKIT S, Mushiroda T, Yanai H, Wichukchinda N, et al
    NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
    Int J Tuberc Lung Dis. 2016;20:1364-1369.
    PubMed     Abstract available


  681. THIEL BA, Bark CM, Nakibali JG, van der Kuyp F, et al
    Reader variability and validation of the Timika X-ray score during treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1358-1363.
    PubMed     Abstract available


  682. PARCHURE R, Kulkarni V, Gangakhedkar R, Swaminathan S, et al
    Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
    Int J Tuberc Lung Dis. 2016;20:1348-1353.
    PubMed     Abstract available


  683. TOLLEFSON D, Ngari F, Mwakala M, Gethi D, et al
    Under-reporting of sputum smear-positive tuberculosis cases in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1334-1341.
    PubMed     Abstract available


  684. SENKORO M, Kumar AM, Chinnakali P, Mfinanga SG, et al
    Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania.
    Int J Tuberc Lung Dis. 2016;20:1326-1333.
    PubMed     Abstract available


  685. ENANE LA, Lowenthal ED, Arscott-Mills T, Matlhare M, et al
    Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Int J Tuberc Lung Dis. 2016;20:1320-1325.
    PubMed     Abstract available


  686. STILLSON CH, Okatch H, Frasso R, Mazhani L, et al
    'That's when I struggle' ... Exploring challenges faced by care givers of children with tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2016;20:1314-1319.
    PubMed     Abstract available


  687. SULIS G, Gnanou S, Roggi A, Konseimbo A, et al
    Active tuberculosis case finding among pregnant women: a pilot project in Burkina Faso.
    Int J Tuberc Lung Dis. 2016;20:1306-1308.
    PubMed     Abstract available


  688. MUNANG ML, Browne C, Evans JT, Smith EG, et al
    Programmatic utility of tuberculosis cluster investigation using a social network approach in Birmingham, United Kingdom.
    Int J Tuberc Lung Dis. 2016;20:1300-1305.
    PubMed     Abstract available


  689. TEBRUEGGE M, Buonsenso D, Brinkmann F, Noguera-Julian A, et al
    European shortage of purified protein derivative and its impact on tuberculosis screening practices.
    Int J Tuberc Lung Dis. 2016;20:1293-1299.
    PubMed     Abstract available


  690. TREBUCQ A, Schwoebel V
    Numbers of tuberculosis cases: dreams and reality.
    Int J Tuberc Lung Dis. 2016;20:1288-1292.
    PubMed     Abstract available


  691. LONG R, Lau A
    How R G Ferguson's groundbreaking studies influenced our understanding of tuberculosis reinfection. Where to next?
    Int J Tuberc Lung Dis. 2016;20:1285-1287.
    PubMed    


  692. LONNROTH K, Shah NS, Lange C
    State-of-the-art series on tuberculosis and migration.
    Int J Tuberc Lung Dis. 2016;20:1280-1281.
    PubMed    


    May 2016
  693. NICOLINI A, Perazzo A, Gatto P, Piroddi IM, et al
    A rare adverse reaction to ethambutol: drug-induced haemolytic anaemia.
    Int J Tuberc Lung Dis. 2016;20:704-5.
    PubMed     Abstract available


  694. MUKHERJEE A, Velpandian T, Singla M, Kanhiya K, et al
    Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Int J Tuberc Lung Dis. 2016;20:666-72.
    PubMed     Abstract available


  695. RUAN YZ, Li RZ, Wang XX, Wang LX, et al
    The affordability for patients of a new universal MDR-TB coverage model in China.
    Int J Tuberc Lung Dis. 2016;20:638-44.
    PubMed     Abstract available


  696. MODI M, Sharma K, Sharma M, Sharma A, et al
    Multitargeted loop-mediated isothermal amplification for rapid diagnosis of tuberculous meningitis.
    Int J Tuberc Lung Dis. 2016;20:625-30.
    PubMed     Abstract available


  697. MOK Y, Tan TY, Tay TR, Wong HS, et al
    Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert(R) MTB/RIF?
    Int J Tuberc Lung Dis. 2016;20:619-24.
    PubMed     Abstract available


    April 2016
  698. BANDA H, Robinson R, Thomson R, Squire SB, et al
    The 'Practical Approach to Lung Health' in sub-Saharan Africa: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:552-9.
    PubMed     Abstract available


  699. YU J, Wang ZJ, Chen LH, Li HH, et al
    Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:494-9.
    PubMed     Abstract available


  700. WANG F, Hou HY, Wu SJ, Zhu Q, et al
    Using the TBAg/PHA ratio in the T-SPOT((R)).TB assay to distinguish TB disease from LTBI in an endemic area.
    Int J Tuberc Lung Dis. 2016;20:487-93.
    PubMed     Abstract available


  701. SILVA AP, Hill P, Belo MT, Rabelo SG, et al
    Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil.
    Int J Tuberc Lung Dis. 2016;20:479-86.
    PubMed     Abstract available


  702. KELLY AM, Smith B, Luo Z, Given B, et al
    Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment.
    Int J Tuberc Lung Dis. 2016;20:442-7.
    PubMed     Abstract available


    March 2016
  703. COWAN J, Michel C, Manhica I, Mutaquiha C, et al
    Remote monitoring of Xpert(R) MTB/RIF testing in Mozambique: results of programmatic implementation of GxAlert.
    Int J Tuberc Lung Dis. 2016;20:335-41.
    PubMed     Abstract available


    February 2016
  704. YANG HK, Park MJ, Lee JH, Lee CT, et al
    Incidence of toxic optic neuropathy with low-dose ethambutol.
    Int J Tuberc Lung Dis. 2016;20:261-4.
    PubMed     Abstract available


  705. SIDIQ Z, Hanif M, Chopra KK, Khanna A, et al
    Random blinded rechecking of AFB smears in a pilot project at an intermediate reference laboratory.
    Int J Tuberc Lung Dis. 2016;20:252-6.
    PubMed     Abstract available


  706. MBONZE NB, Tabala M, Wenzi LK, Bakoko B, et al
    Xpert((R)) MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo.
    Int J Tuberc Lung Dis. 2016;20:240-6.
    PubMed     Abstract available


  707. SABI I, Kabyemera R, Mshana SE, Kidenya BR, et al
    Pulmonary TB bacteriologically confirmed by induced sputum among children at Bugando Medical Centre, Tanzania.
    Int J Tuberc Lung Dis. 2016;20:228-34.
    PubMed     Abstract available


  708. ELIAS D, Akuffo H, Abate E, Mekonnen Y, et al
    Risk of tuberculous infection in adolescents and adults in a rural community in Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:218-22.
    PubMed     Abstract available


  709. KERKHOFF AD, Meintjes G, Opie J, Vogt M, et al
    Anaemia in patients with HIV-associated TB: relative contributions of anaemia of chronic disease and iron deficiency.
    Int J Tuberc Lung Dis. 2016;20:193-201.
    PubMed     Abstract available


  710. BONNET M, Bastard M, du Cros P, Khamraev A, et al
    Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
    Int J Tuberc Lung Dis. 2016;20:177-86.
    PubMed     Abstract available


  711. NIKAM C, Patel R, Sadani M, Ajbani K, et al
    Redefining MTBDRplus test results: what do indeterminate results actually mean?
    Int J Tuberc Lung Dis. 2016;20:154-9.
    PubMed     Abstract available


  712. GLAZIOU P, Floyd K, Weil D, Raviglione M, et al
    TB deaths rank alongside HIV deaths as top infectious killer.
    Int J Tuberc Lung Dis. 2016;20:143-4.
    PubMed    


    January 2016
  713. KO Y, Lee HK, Lee YS, Kim MY, et al
    Accuracy of Xpert((R)) MTB/RIF assay compared with AdvanSure TB/NTM real-time PCR using bronchoscopy specimens.
    Int J Tuberc Lung Dis. 2016;20:115-20.
    PubMed     Abstract available


  714. BENERI CA, Aaron L, Kim S, Jean-Philippe P, et al
    Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.
    Int J Tuberc Lung Dis. 2016;20:93-100.
    PubMed     Abstract available


  715. KAPOOR S, Gupta A, Shah M
    Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
    Int J Tuberc Lung Dis. 2016;20:85-92.
    PubMed     Abstract available


  716. HENSEL RL, Kempker RR, Tapia J, Oladele A, et al
    Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.
    Int J Tuberc Lung Dis. 2016;20:71-8.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: